Cationic antimicrobial peptides (CAMPs) are novel candidates for drug development. Here we describe design of six short and potent CAMPs (SA-1 to SA-6) based on a minimalist template of 12 residues H+ HHG+HH+HH+NH2 (where H: hydrophobic amino acid and +: charged hydrophilic amino acid). Designed peptides exhibit good antibacterial activity in micro molar concentration range (1-32 μg/ml) and rapid clearance of Gram-positive and Gram-negative bacterial strains at concentrations higher than MIC. For elucidating mode of action of designed peptides various biophysical studies including CD and Trp fluorescence were performed using model membranes. Further based on activity, selectivity and membrane bound structure; modes of action of Trp rich peptide SA-3 and template based peptide SA-4 were compared. Calcein dye leakage and transmission electron microscopic studies with model membranes exhibited selective membrane active mode of action for peptide SA-3 and SA-4. Extending our work from model membranes to intact E. coli ATCC 11775 in scanning electron micrographs we could visualize different patterns of surface perturbation caused by peptide SA-3 and SA-4. Further at low concentration rapid translocation of FITC-tagged peptide SA-3 into the cytoplasm of E. coli cells without concomitant membrane perturbation indicates involvement of intracellular targeting mechanism as an alternate mode of action as was also evidenced in DNA retardation assay. For peptide SA-4 concentration dependent translocation into the bacterial cytoplasm along with membrane perturbation was observed. Establishment of a non specific membrane lytic mode of action of these peptides makes them suitable candidates for drug development.
Infections caused by multidrug-resistant Gram-positive and Gramnegative pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterrococci (VRE), drug-resistant Pseudomonas aeruginosa and Acenatobacter spp. has become a serious problem worldwide [1] [2] [3] . Although there are some antibacterial drugs in the market but withdrawal of major drug companies from the antibacterial drug development market has lead to a lack of new molecules in the clinics [4, 5] . Therefore search for innovative antibacterial agents with novel mode of action has become inevitable. Although peptides are high-priced solution as a new class of antibiotics, their multifaceted roles in innate immunity, LPS neutralisation, wound and burn healing makes them attractive candidates for drug development [6] . With a non-specific cell lytic mode of action and a broad range of activity CAMPs can combat attack of pathogens including bacteria, fungi, viruses, protozoa and cancerous cells [7] . A multicellular organism in general attack microbes with multiple peptides at the same time, and each peptide with a different primary sequence and secondary structure preference may have a different mode of action thus it would be difficult for the bacteria to endure or gain resistance against CAMPs [8] . Therefore potential of CAMPs can be harnessed by rational designing of short, potent and highly specific peptide therapeutics.
CAMPs represent a diverse array of small peptides with length of 12-60 amino acid residues, found in almost all organisms including
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Abbreviations: CAMPs, Cationic Antimicrobial Peptides; ATCC, American Type Culture Collection; CFU, Colony Forming Units; Chol, cholesterol; DPPC, 1,2-dipalmitoyl-sn-Glycero-3-phosphocholine; DPPG, 1,2-dipalmitoyl-sn-Glycero-3-phospho-(1'-rac-Glycerol) (sodium salt); FITC, Fluorescein isothiocyanate; Fmoc, Fluorenyl methoxy carbonyl; LUVs, large unilamellar vesicles; MIC, Minimum inhibitory concentration; PBS, Phosphate buffer saline; PI, propidium iodide; PTA, phospho tungstic acid; RPHPLC, Reverse Phase High Performance Liquid Chromatography; SEM, Scanning Electron Microscopy; SUVs, small unilamellar vesicles; TEM, Transmission Electron Microscopy mammals, amphibians, plants and even bacteria [9] . Different classes of CAMPs based on secondary structure includes family of amphipathic α-helical peptides like cecropins, β-sheet peptides like defensins, loop structured peptides like bactenecins and peptides rich in one particular amino acid like indolicidin [10] . Among the major modulators that determine antimicrobial activity of a peptide are net positive charge, length, hydrophobicity and amphipathic structure [11] . Initial interactions between a peptide and bacterial membranes are electrostatically driven as bacterial membranes are composed of negatively charged and zwitterionic phospholipids therefore positive charge on these peptides helps them to bind to these membranes [12] . Amphipathicity plays a key role in peptide lipid interactions as acquisition of a well defined amphipathic structure in the vicinity of membrane lowers the thermodynamic cost of peptide partitioning in lipid membranes. This energy lowering helps in binding and insertion of peptides to bacterial membranes that lead to bacterial cell death.
For the design of novel, short and potent CAMPs various research groups have made use of a sequence template approach whereby based on amphipathicity novel peptides with amino acid residues occurring most frequently in the sequences of CAMPs were employed to design cell selective antimicrobial agents [13, 14] . The specific mode of action of CAMPs has not been deciphered as yet because of the fact that they do not attack a single target such as a membrane receptor or an enzyme in bacterial pathogens [15, 16] . It has been established that if not all, most of the CAMPs are membrane active and need to interact with the bacterial membrane to perturb the membrane or to target intracellular components. Among the major hypothesis proposed for mode of action of membrane permeabilizing peptides a few are (a) loss of ion concentration gradient across the membrane leading to leakage of cellular contents (b) intracellular targeting after internalization like DNA and RNA synthesis inhibition, enzyme deactivation and lipid binding [17] (c) generation of pores that admit water but do not allow other osmotically active substances to pass, which leads to swelling of the bacterial cell and finally rupturing of the cell. A novel mode of action proposed recently for activity of a group of conformationally amphipathic molecules includes lipid segregation caused upon peptide lipid interaction that ends up in membrane damage of bacteria due to clustering of anionic lipids [18] .
In the present study we undertook synthesis of a series of short cationic peptides based on an amphipathic template of 12 amino acid residues with different secondary structure preferences in membrane milieu. Antibacterial activities of the designed peptides against various Gram-positive and Gram-negative bacterial strains were tested. Toxicity to hRBC was evaluated as a measure to check selectivity of designed peptides. Based on the results of antimicrobial activity, cytotoxicity, CD spectra and Trp fluorescence in our further studies, we compared mode of action of two of the lead peptides SA-3 and SA-4 by employing biophysical, microscopic, flow cytometric and DNA gel retardation tools.
In the studies bovine peptide indolicidin (rich in Trp residues) was included as a standard CAMP because of its comparable length and well established mode of action.
Materials and methods

Chemicals
Fmoc-Protected amino acids and resins were purchased from Nova Biochem. Piperidin, N-hydroxybenzotrizole (HOBt), trifluoro ethanol (TFE), trifluoro acetic acid (TFA), N-methyl pyrrolidinone (NMP), N,Ndiisopropylcarbodiimide (DIPCDI), dimethyl sulphoxide (DMSO) and triisopropyl silane (TIS) were purchased from Sigma Chemical Co. DPPC, DPPG were purchased from Avanti Polar Lipids. Calcein, propidium iodide, FITC and buffer material were purchased from Sigma Chemicals Co. All solvents used for the purification were HPLC grade and obtained from Sigma chemical Co. Dimethylformamide (DMF) and dichloromethane (DCM) were obtained from Merck. DMF was double distilled prior to use.
Bacterial strains
Bacterial strains used in this study were as follows, Escherichia coli (ATCC 11775), P. aeruginosa (ATCC 25668), S. aureus (ATCC 9144), Bacillus subtilis (ATCC 6633), Acinetobactor spp. (clinical isolate), and E. coli (clinical isolate). Clinical isolates used in the present study were collected from hospital patients from All India institute of Medical Sciences, New Delhi, India. All the strains used in the study were maintained and tested on Mueller-Hinton broth and agar (Himedia).
Peptide synthesis and purification
All peptides were synthesized manually following standard Fmocsolid phase protocols using Rink amide MBHA resin (Nova Biochem, loading 0.56 mM/g) as solid support [19] . FITC labeled peptides were synthesized by method described earlier [20] . Purification of all the peptides was performed on C-18 preparative RPHPLC column. The RPHPLC analysis of peptides was performed on a Waters column (4.6 × 250 mm, 300 Å, 5-μm particle size) with linear gradients of water containing 0.05% TFA (gradient A) and acetonitrile containing 0.05% TFA (gradient B) at a flow rate of 0.8 ml/min and with 1% gradient B/min, starting at a concentration of 10% gradient B. After purification the correct peptide sequences were confirmed by MALDI-TOF (Kratos) mass determination and by automated peptide sequencing (490 Applied Biosystems). Characterization of the FITC labeled peptides was done using SDS-PAGE methodology.
Antimicrobial activity
Antimicrobial susceptibility testing was carried out using a modification of the Clinical Laboratory Standard Institute (CLSI) micro dilution broth assay [21] . Briefly, the inoculums were prepared from mid-logarithmic phase bacterial cultures. Each well of 96-well polypropylene micro titre plate (SIGMA) was inoculated with 90 μl of approximately 10 5 CFU/ml of bacterial suspension per ml of Mueller-Hinton broth (HIMEDIA). Then 10 μl of serially diluted peptides in 0.001% acetic acid and 0.2% bovine serum albumin (SIGMA) over concentration ranging from 0.5 μg/ml to 512 μg/ml was added to the wells of micro titre plate. The micro titre plates were incubated overnight with agitation at 37°C and after 18 h the absorbance was read at 630 nm. Cultures (approximately 10 5 CFU/ ml) without peptide were used as positive control. Uninoculated Mueller-Hinton broth was used as negative control. The tests were carried out in duplicate. The minimum inhibitory concentration (MIC) is defined as the lowest concentration of peptide that completely inhibits growth.
Bactericidal kinetics
The kinetics of bacterial killing of the peptides was evaluated using E. coli (ATCC 11775) and S. aureus (ATCC 9144). Log-phase bacteria (3 × 10 7 CFU / ml) were incubated with different peptides at 2 × MIC of respective peptide in Muller Hinton media. Aliquots were removed at fixed time interval, diluted up to 10 8 , plated on the MHA agar plate and CFU were counted after 24 h incubation at 37°C. Data were obtained from two independent experiments performed in duplicate.
Hemolytic activity
Hemolytic activity of the peptides was determined using human red blood cells (hRBC). The hRBC were centrifuged for 15 min to remove the buffy coat and washed three times with phosphatebuffer saline (35 mM phosphate buffer, 150 mM NaCl pH 7.2). One hundred microliters of the hRBC suspended 4% (v/v) in PBS was plated into sterilized 96-well plates and then 100 μl peptide solution ( serial twofold dilution in PBS) was added to each well. The plates were incubated for 1 h at 37°C without agitation and centrifuged at 1000g for 5 min. Aliquots (100 μl) of the supernatant were transferred to 96-well plates, where hemoglobin release was monitored using ELISA plate reader (Molecular devices) by measuring the absorbance at 414 nm. Percent hemolysis was calculated by the following formula:
Percentage hemolysis = 100 A−A 0 ð Þ = A t −A 0 ð Þ ½ Where A represents absorbance of peptide sample at 414 nm and A 0 and A t represent zero percent and 100% hemolysis determined in PBS and 1% Triton X-100, respectively.
Proteinase K digestion assay
Proteinase-K digestion assay was performed using RP-HPLC as described previously [22] . Digestion of peptides SA-1 and SA-4 as representatives of gene encoded and non-gene encoded amino acid containing peptides was carried out by treating 50 μg/ml of peptide with 2 μg/ml Proteinase-K in 100 mM Tris buffer pH 7.6 at 25°C. The peptide cleavage after 30, 60, 90 and 120 min was monitored by HPLC using C18 reverse phase column. Linear gradient of 0.1% aqueous TFA and 0.1% TFA in acetonitrile were run. Absorbance was measured at 220 nm. Digestion was measured as percentage of degraded peptide calculated from the decrease of the HPLC peak area of the native peptide.
Tryptophan fluorescence Blue shift
In the tryptophan fluorescence blue shift experiment, small unilamellar vesicles (SUVs) were used to minimize differential light scattering effects [23] . Similar procedure was used for preparation of SUVs as described earlier [24] . Briefly dry lipids [DPPC/DPPG (7:3, w/w) or DPPC/cholesterol (10:1, w/w)] were dissolved in chloroform/ methanol mixture in a small glass vessel. Solvent was removed by a stream of nitrogen gas, so that a thin lipid film was formed on the walls of the glass vessel. The lipid film thus obtained was then lyophilized overnight. Dried thin films were re suspended in 10 mM Tris-HCl buffer [0.1 mM EDTA and 150 mM NaCl (pH 7.4)] by vortex mixing. The lipid dispersions were then sonicated in ice for 15-20 min using titanium-tip ultrasonicator with a burst and pulse time of 20 second and 5 second respectively until the solution became opalescent. Titanium debris was removed by centrifugation. Each peptide (final concentration of 5 μM) was added to 500 μl of 10 mM Tris buffer [0.1 mM EDTA and 150 mM NaCl (pH 7.4)] containing 0.5 mM liposome, and the peptide/liposome mixture was allowed to interact at 20°C for 2 min. The fluorescence measurements were done using Fluoromax 4 (spex) spectrofluorimeter. Samples were excited at 280 nm, and the emission was scanned from 300 to 400 nm.
Preparation of LUVs for CD spectroscopy
CD spectroscopy analysis of peptides was done in buffer, helix inducing solvent TFE (50% v/v) and bacterial mimic LUVs. LUVs were prepared as described previously [25] . Briefly desired mixtures of the lipids DPPC: DPPG (7:3) was mixed in 2 ml chloroform/methanol mixture in a 150-ml round bottom flask. The solvent was removed under a stream of nitrogen and the lipid film obtained was lyophilized overnight to remove any trace of solvent. The thin lipid film was rehydrated with 10 mM sodium phosphate buffer, vortex mixed for half an hour on a water bath kept above the phase transition temperature of the lipid mixture. The multilamellar vesicles thus obtained were extruded 16 times through a 100 nm polycarbonate membrane extruder (Avanti mini extruder apparatus). Mean diameter of LUVs was determined by dynamic light scattering, using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Mean diameter of LUVs was found to be in the range of 110-115 nm.
C D spectroscopy
The Circular Dichroism (CD) spectra of the peptides were recorded using a Jasco J-715 CD spectrophotometer (Tokyo, Japan) with a 1 cm path length cell. Wavelengths from 200 to 260 nm were scanned with 1.0 nm step resolution, 100 nm/min speed, 0.4 second response time, and 1 nm bandwidth. CD spectra of the peptides were collected and averaged over two scans in 10 mM sodium phosphate buffer (pH 7.2), helix inducing solvent TFE 50% (v/v) and bacterial mimic LUVs( 680 μM lipid). Spectra were baseline corrected by subtracting a blank spectrum containing only buffer or LUVs. The spectra were expressed as ellipticity [θ] vs. wavelength.
Calcein dye leakage assay
In order to assess ability of the designed peptides to cause leakage of liposomal content, LUVs composed of bacterial mimic membrane (DPPC:DPPG, 7:3, w/w) or mammalian mimic membrane (DPPC/ Chol, 10:1, w/w) were used. LUVs were prepared as described in section 2.9 except the dry lipid films were rehydrated with 10 mM Tris-HCl [70 mM calcein, 150 mM NaCl, 0.1 mM EDTA]. After addition of calcein, pH of the LUVs mixture drop down, to make it up to 7.2 a few drops of sodium hydroxide solution (1 M) were added. The liposome suspension obtained after rehydration was freeze thawed for five cycles and extruded 16 times through two stacked polycarbonate filters (100 nm pore size). The free calcein was removed by passing the liposome suspension through a Sephadex G-50 column at 23°C and eluting with a buffer containing 10 mM Tris-HCl [150 mM NaCl, 0.1 mM EDTA]. After passing the liposome through Sephadex G-50, liposome diameter was measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments). Average diameter of LUVs was found to be in the range of 110-130 nm. Leakage of calcein from the LUVs was monitored by measuring the fluorescence intensity at an excitation wavelength of 490 nm and an emission wavelength of 520 nm on a model Fluoromax 4 (spex) spectrofluorimeter. Different concentrations of peptides were incubated with bacterial mimic liposome for 5 min before exciting the samples. For comparison indolicidin was used as a standard peptide. For the determination of 100% dye leakage 1% Triton X-100 (20 μl) in 10 mM Tris-HCl buffer [150 mM NaCl, 0.1 mM EDTA] was added to dissolve the liposome. The percentage of dye leakage caused by the peptides was calculated using the formula
Where F is the fluorescence intensity achieved by the peptides and F 0 and F t are fluorescence intensities in buffer and with Triton X-100, respectively. All measurements were made in triplicate. Phosphate assay was performed with the lipid mixture to determine the exact concentration of lipids for the leakage experiment [26] .
Transmission electron microscopy
Large unilamellar vesicles for TEM analysis were prepared in a similar fashion as has been described in section 2.9. [DPPC/DPPG (7:3, w/w)] was used as model membrane representing bacterial mimic membrane. Peptide SA-3 or SA-4 were incubated (for 30 min) with LUVs at 25°C in 10 mM sodium phosphate buffer at a peptide concentration 10 μg/ml. After incubation with peptide the liposome suspension was applied to glow-discharged carbon-coated copper grids for 1 min. The grids were rinsed in the same buffer, and stained with 2% PTA. Electron micrographs were then recorded using FEI Morgagni 268(D) operated at 70 kV.
Scanning electron microscopy
E. coli (ATTC 11775) cells were suspended at 10 8 CFU/ml in 10 mM PBS, pH 7.4 supplemented with 100 mM NaCl, and incubated at 37°C with peptides SA-3 or SA-4 at 10× MIC. Controls were run in the absence of peptides. After 30 min the cells were fixed with an equal volume of 4% glutaraldehyde in 0.2 M Na-cacodylate buffer, pH 7.4, for 3 h at 4°C followed by dehydration with graded series of ethanol and dried the sample in HMDS (hexamethyl disilazane). Coating was done with gold approximately 20 nm thicknesses and observed under scanning electron microscope (Leo 435 VP).
Confocal laser scanning microscopy
E. coli (ATCC 11775) cells in mid-logarithmic phase were harvested by centrifugation, washed three times with phosphate buffer saline 10 mM, pH 7.3. E. coli (10 7 CFU/ml) cells were incubated with FITC labeled peptides SA-3 or SA-4 at 5 μg/ml and 10 μg/ml at 37°C for 30 min (MIC of FITC tagged peptides was evaluated against E. coli cells, no effect was observed on MIC of peptide SA-3 whereas for peptide SA-4 there was a twofold increment in the MIC value). After being incubated, the bacterial cells were palleted down and washed 3 times with 10 mM sodium phosphate buffer and immobilized on a glass slide. The FITC-labeled peptides were observed with a Zeiss Axioplan 2 optical microscope (Japan). Fluorescent images were obtained with a 488 nm band-pass filter for excitation of FITC.
Flow cytometry
E. coli ATCC 11775 was grown to mid log phase in Mueller-Hinton broth (HIMEDIA), washed thrice with buffer (10 mM Tris, pH 7.4) and resuspended in buffer to obtain 2 × 10 8 CFU/ml bacterial suspension. The bacterial suspension was diluted to 10 5 CFU/ml in the same buffer. Different peptide concentrations (2.5 μg/ml, 5 μg/ml and 10 μg/ml) were incubated with 1 ml of bacterial suspension at fixed PI concentration of 10 μg/ml for 15 min. A FACS flow cytometer (Guava Technologies, Hayward, CA, USA) was used to obtain the data with a wavelength of laser excitation 488 nm. Data were analyzed by Express plus cytosoft software (Guava Technologies, Hayward, CA, USA).
DNA-binding assay
Gel retardation experiments were performed for peptide SA-3, SA-4 and indolicidin (as a standard) as described previously [13] . Briefly 100 ng of the plasmid DNA (pBluescript II SK+) was mixed with increasing amounts of peptide in 20 μl of binding buffer (5% glycerol, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, 20 mM KCl, and 50 μg/ml bovine serum albumin). Reaction mixtures were incubated at room temperature for 1 h. Subsequently, 4 μL of native loading buffer was added (10% Ficoll 400, 10 mM Tris-HCl, pH 7.5, 50 mM EDTA, 0.25% bromophenol blue, and 0.25% xylene cyanol), and a 20-μl aliquot subjected to 1% agarose gel electrophoresis in 0.5 × Tris borate-EDTA buffer (45 mM Tris-borate and 1 mM EDTA, pH 8.0). The plasmid DNA was purchased from Stratagene and was used as such without further purification.
Results
Peptide design and biological activities
In the present study we undertook design and synthesis of membrane active peptides rich in Trp and Lys residues with a template of 12 amino acid residues H + HHG + HH + HH + NH 2 (where H: hydrophobic amino acid and +: charged hydrophilic amino acid residue), +5 charge and an amidated C-terminal. Name, sequence, molecular mass, percentage purity by HPLC and mean hydrophobicity of the designed peptides has been presented in Table 1 . Using key amino acid residues such as Pro and Trp changes were done at the hydrophobic positions of the template. At the charged hydrophilic positions in the template Lys residues were replaced with Orn residues. In accordance with Antimicrobial Peptide Database, using minimalist approach amino acid residues with maximum propensity to be present in CAMPs such as glycine, lysine, alanine, isoleucine, phenylalanine and tryptophan were used. Based on a common template of hydrophobic and hydrophilic amino acid residues initially three peptides (SA-1, SA-2 and SA-3) were generated. Secondary structure prediction tools available online (Antimicrobial peptide database) and SCRATCH servers (Cheng et al. 2005 ; http://www.igb.uci.edu/tools/scratch) predicted helical structure for peptide SA-1. In peptide SA-2 changes were done in the hydrophobic segment of the peptide SA-1 where Trp at position 3 was replaced with Pro (single amino acid substitution) a helix breaker imino acid. It is well known that Trp-rich peptides have enhanced membrane binding properties [27] . For the synthesis of a Trp-rich peptide, in peptide SA-3 two Trp residues were placed adjacent at position 7 and 8 replacing Leu and Phe in peptide SA-1 respectively. Non-gene encoded amino acid Orn was used as a positively charged residue in place of Lys to impart proteolytic stability to designed peptides. In peptide SA-4 all Lys residues of SA-1 were replaced with Orn, in peptide SA-5 all Lys residues of SA-3 were replaced with Orn. SA-6 is acetylated analogue of SA-3. Acetylation of N-terminus of lead peptide SA-3 was done to see the effect of acetylation on antimicrobial activity, selectivity and induced structure in model membranes.
Antimicrobial activity of designed peptides was tested against two Gram-positive (S. aureus and B. subtilis), two Gram-negative (E. coli and P. aeruginosa) and two clinical bacterial isolates (Acenatobacter spp. and E. coli) Table 2 . Peptide SA-1, which is ideally amphipathic exhibited potent antimicrobial activity against all bacterial strains studied. Peptide SA-2 exhibited a poor efficacy at killing all the Gramnegative and Gram-positive bacterial strains with MIC in the range of 64-512 μg/ml. Peptide SA-3 showed 2 to 4 times better potency at killing the bacterial strains as compared to peptide SA-1. It was interesting to see that the antimicrobial activities of peptide SA-4 or SA-5 were not modified to a great extent by incorporation of Orn residue. Acetylated derivative of lead peptide SA-3 was also found to be almost equally active in comparison to peptide SA-3. Major thrust of these peptides is their ability to check growth of multi-drug- [1864] [1865] [1866] [1867] [1868] [1869] [1870] [1871] [1872] [1873] [1874] [1875] resistant clinical isolates in the concentration range of 1-32 μg/ml. In comparison to designed template based peptides (except SA-2) standard peptide indolicidin was found to be less potent at killing bacterial strains used in the present study.
Viability of exponentially growing E. coli and S. aureus as representative Gram-negative and Gram-positive bacterial strains was checked against peptides SA-1, SA-3 and SA-4 by time-kill assay. The time kill curves of peptide SA-1, SA-3 and SA-4 against S. aureus are shown in Fig. 1A and against E. coli in Fig. 1B . With a rapid bactericidal kinetics peptide SA-1 reduced CFU/ml of S. aureus by 2 Log-CFU/ml within 30 min of incubation period at 2× MIC. Most active peptide SA-3 could completely eradicate 10 7 CFU/ml of S.
aureus at 2 × MIC over a period of 1 h whereas peptide SA-4 took 2 h to completely eradicate 10 7 CFU/ml. In accordance with MIC data peptide SA-3 exhibited rapid killing rate against E. coli causing almost 5 log unit reductions in CFU/ml over a period of 30 min and complete killing activity within 1 h. Peptide SA-1 also caused significant reduction in CFU/ml of E. coli within 30 min however it took 90 min to remove complete growth. Peptide SA-4 was less rapid in its mode of action and could never eradicate complete growth over a period of 2 h (Fig. 1B) .
To analyze stability imparted to peptides by incorporation of Orn residues we compared time course analysis of percentage digestion of peptides SA-1 and SA-4 with Proteinase-K. Data are represented in the form of percentage degradation of peptides against time by measuring area under the major peak in RPHPLC chromatogram of Proteinase-K treated peptides (Fig. 3) . As the digestion data suggest, both the peptides SA-1 and SA-4 (all Orn analog of SA-1) showed almost 25% digestion within a period of 30 min after incubation with Proteinase-K. There on percentage digestion of SA-1 increases rapidly leading to 78% digestion in 2 h whereas peptide SA-4 is digested to 51% of total peptide content. The data suggest incorporation of Orn into the sequence of SA-1 enhances proteolytic stability of the peptides to some extent.
Selectivity of designed peptides for bacterial membranes over mammalian membranes and induced secondary structure
Hemolytic activity of the synthetic peptides was studied as a measure of toxicity against human erythrocytes. 1% Triton-X 100 was used for complete hemolysis. Results of hemolytic activity are presented in Fig. 2 . Peptide SA-1 was found to be hemolytic among all the peptides designed. Peptide SA-1exhibited 85% hemolysis of hRBC at 512 μg/ml. Interestingly when all Lys of SA-1 were replaced by Orn (SA-4), drastic reduction in hemolytic activity was observed. It seems that whereas replacement of Lys with Orn has no appreciable effect on antimicrobial activity of the designed peptides, it certainly had a remarkable effect on the hemolytic activities of the designed peptides. Peptides SA-2, SA-3, SA-4 and SA-5 were non-hemolytic up a Clinical isolates used in the present study were collected from All India Institute of Medical Sciences, New Delhi, India. Antibiotics against which the clinical isolates were found to be resistant were amikacin, netilmicin, ciprofloxacin, cefoparazone, piperacillin, piperacillin-tazobactam, imipenem and cefotaxim. to 512 μg/ml. Peptide SA-6 exhibited 30% hemolysis of hRBC at 512 μg/ml. Indolicidin was found to cause damage to the hRBC from a low concentration of 64 μg/ml and caused almost 87% hemolysis up to 512 μg/ml. To analyze environment of Trp residue(s) of peptides in model membranes, SUVs of representative compositions were used. Trp fluorescence spectra of peptides SA-1 to SA-6 (except SA-2) and indolicidin (as a standard peptide) were recorded in 10 mM Tris buffer (0.1 mM EDTA and 150 mM NaCl, pH 7.4) or in the presence of vesicles composed of either zwitterionic phospholipids [DPPC/ Cholesterol (10:1, w/w) SUVs] or negatively charged phospholipids [DPPC/DPPG (7:3, w/w) SUVs]. In buffer the emission maxima for all the peptides was found to be in the range of 355-360 nm. In negatively charged vesicles, single Trp containing peptides SA-1 and SA-4 showed large blue shifts in the emission maxima of Trp residue (Table 3) . Relatively lower as compared to peptide SA-1 and SA-4 and almost comparable blue shifts were observed for peptides SA-3, SA-5, SA-6 and indolicidin in bacterial mimic SUVs. Maximum blue shift in emission maxima was observed for peptide SA-1 (28 nm). A blue shift of 14 nm observed for indolicidin in bacterial mimic membrane which is in accordance with the literature [13] . In mammalian mimic SUVs a blue shift in the range of 3-10 nm was observed for all the peptides, which is very less as compared to blue shift in bacterial mimic membranes. In order to elucidate secondary structure of peptides, CD spectra of peptides in buffer, helix inducing solvent TFE (50%, v/v) and bacterial mimic LUVs was acquired. Results of CD experiment for peptide SA-1 to SA-6 are presented in Fig. 4 . CD spectra of peptides in 10 mM sodium phosphate buffer (pH 7.2) are random coil for peptide SA-1, SA-2, SA-3 and SA-4 showing minima in the range of 202-212 nm for the peptides. For peptide SA-5 in buffer a negative band at 218 nm and a positive band at 204 nm was observed. For peptide SA-6 in buffer a minimum at 240 nm and a positive band at 212 nm was obtained. Although in 50% TFE peptide SA-1 and SA-4 are unable to gain a helical structure these two peptides were able to acquire helical conformation in the presence of bacterial mimic LUVs with double minimum at 208 nm and 222 nm. [28] . For peptide SA-4 in bacterial mimic membrane the general curve similar to the canonical structure of an alpha helical peptide was obtained, however the band at 208 nm was slightly shifted to higher wavelength.CD spectra of peptides SA-2 exhibited some ordering in bacterial mimic LUVs though not helical in particular. In bacterial mimic LUVs peptides SA-3 and SA-5 exhibited a deep minimum in the range of 230-232 nm typically representing aromatic stacking of two adjacent Trp residues at position 7 and 8 of the peptides [29] . For peptide SA-6 in bacterial mimic LUVs a minima at 231 nm and positive bands at 222, 217 and 212 nm can be attributed to aromatic stacking (negative band) as well as turn structure [30] .
Peptide-lipid interactions using model membranes
Further for comparing membrane interactions of a template based peptide SA-1 and SA-4 with selective Trp-rich peptide SA-3 we studied the ability of the peptides to cause membrane leakage by testing their ability to evoke calcein release from LUVs made from negatively charged and zwitterionic phospholipids. For the study, calcein encapsulated LUVs were used at a concentration of 70 mM calcein, a concentration at which fluorescence of calcein is selfquenched. Upon treatment of calcein encapsulated LUVs with peptides if the peptide is able to break the liposomal shell thereby leading to outburst of calcein into the aqueous environment, the dye starts fluorescing and thus the fluorescence signal intensity increases. Data were obtained after equilibrating the samples for 5 min after peptide addition to obtain stable fluorescence values. The doseresponse curves of peptide-induced calcein release are shown in Fig. 5 . Peptide SA-1 caused maximum leakage of calcein dye up to 76% at the maximum concentration tested. The order for the relative extent of calcein leakage from negatively charged vesicles was SA-1, SA-3, indolicidin and SA-4. On comparing leakage profile of peptide SA-3 and SA-4 from bacterial mimic LUVs [DPPC:DPPG, 7:3,w/w] it is evident that peptide SA-3 caused a graded release of calcein dye which starts at a low concentration and thereafter remains constant up to the maximum concentration tested of 5.5 μg/ml. For peptide SA-4 as the concentration increases a sharp increase in leakage of encapsulated calcein dye was observed.Calcein leakage data end in plateaus for all three peptides except peptide SA-4. Leakage data with mammalian mimic DPPC: chol (10:1, w/w) with all the peptides at the maximum exhibited up to 11% leakage of calcein dye at the highest concentration of 8.8 μg/ml tested (data not presented here). Leakage data for indolicidin included as a standard peptide in the study correlates well with earlier reports on low leakage inducing potential for the peptide [25] .
Knowing the peptides are acting on the surface of bacterial membrane TEM studies were conducted with peptide SA-3 or SA-4 at a concentration of 10 μg/ml with LUVs composed of (DPPC: DPPG, 7:3 w/w) bacterial mimic membranes. TEM studies were conducted to visualize effect of peptides on the model membranes and the results showed surface alterations of the liposome. To ensure validity of images obtained as a result of peptide liposome interaction only separate copper grids were used to reproduce the results with the same sample. Peptide SA-3 caused deformation of the surface of the liposome making pores or channels in the surface of the liposome (Fig. 6B) . Earlier reports in literature have reported aggregation of negatively charged vesicles or deformation of liposome as a result of lipid peptide interaction [31] . Peptide SA-4 treated liposomes (14) 349 (8) a Blue shift in emission maxima in parentheses. appeared empty and deformed due to leakage of internal buffer content (Fig. 6C) .
Surface disruption and internalization of designed peptides in E. coli ATCC 11775 along with a comparative DNA binding assay
Extending our study from model membranes to intact E. coli ATCC 11775 we visualized morphological alterations of peptide on E. coli cells. E. coli cells treated with peptides at 10 × MIC were visualized. Untreated E. coli cells exhibited bright and smooth surface (Fig. 7A) . Upon treatment of E. coli cells with peptide SA-3 at 10 × MIC well defined pores could be visualized on the surface of bacterial cell (Fig. 7B) . On the other hand on treatment of E. coli with peptide SA-4 surface blebs were spotted on the surface of E. coli (Fig. 7C) . It was evident from the SEM data that peptide SA-3 and SA-4 take up two different patterns of membrane perturbation.
For the determination of site of action of the designed peptides, FITC-labeled peptides SA-3 and SA-4 were incubated with log phase E.
coli ATCC 11775 and their localization was visualized by confocal laser-scanning microscopy. E. coli cell treated for half an hour with FITC labeled peptide SA-3 (5 μg/ml) at room temperature appeared as green rods with fluorescence spread throughout the bacterial cell indicating internalization of FITC-labeled peptides into the cytoplasm of the bacteria (Fig. 8B) . It was observed that peptide FITC-SA-4 was able to traverse bacterial membrane at 10 μg/ml concentration along with cell damage and was unable to translocate at low concentration ( Fig. 8D and E) . Confocal data suggest that peptide SA-4 needed a threshold concentration to traverse into the bacterial membranes.
Using a bacterial cell density of E. coli (ATCC 11775) in the range of 10 5 , flow cytometric analysis was performed to understand the concentration dependent internalization potentials of the lead peptides SA-3 and SA-4. In flow cytometric analysis permeability of a DNA intercalating dye propidium iodide into the compromised cell membrane of E. coli was studied. In the experiment as negative control E. coli ATCC 11775 cells were incubated with PI without any test peptide. For permeabilization monitoring E. coli ATCC 11775 was coincubated with various peptide concentrations (2.5, 5, 10 μg/ml) at a fixed concentration of PI (10 μg/ml). Bovine indolicidin with welldefined non-membrane perturbing mode of action was included in the study as a reference peptide. Results of the experiment are presented in Fig. 9 . Rapid increase in PI fluorescence was observed for peptide SA-3 at 5 μg/ml (29% cells stained with PI) however peptide SA-4 caused only minimal increase in the fluorescence at 5 μg/ml. At 10 μg/ml peptide SA-3 was able to cause rapid increase in PI fluorescence with 86% cells stained with PI. For peptide SA-4 at 10 μg/ml only 20% cells were stained with PI. According to the data indolicidin was unable to traverse the bacterial membranes up to 10 μg/ml with only 7% cell stained with PI.
To explore intracellular targeting mechanisms we compared the DNA binding affinity of the two peptides SA-3 and SA-4 ( Fig. 10) . The gel retardation assay was examined by analyzing the electrophoretic mobility of DNA bands at various ratios of peptide to DNA on a 1% agarose gel. Peptide SA-3 caused a decrease in DNA movement starting from a concentration of 5 μg/ml whereas indolicidin started retardation at a concentration of 10 μg/ml and SA-4 retarded DNA movement to a much lesser extent after 20 μg/ml.
Discussion
Design of antimicrobial peptides based on sequence analogy and amphipathicity has been exploited widely by different research groups to design novel antimicrobial peptides [32, 33] . In the present study based on minimalist template approach we obtained short and potent CAMPs with activity against a number of bacterial strains including Gram-positive, Gram-negative and multidrug-resistant Gram-negative bacterial strains. In order to clarify mode of action of designed peptides (SA-1 to SA-6), peptide-lipid interactions including structure acquisition propensity and assessment of environment of Trp residue were carried out using model membranes. Based on these results and toxicity (measured in terms of hemolytic activity) profiles of the peptides, we further aimed to have insight into the detailed mode of interaction of peptides SA-3 and SA-4 with model membranes as well as E. Coli ATCC 11775. For Trp-rich peptide SA-3 rapid membrane translocation along with transient pore formation (as evidenced by calcein leakage) was observed at low concentrations implying role of intra cellular targeting as mode of action (which was also corroborated by better DNA binding affinity) whereas for template based peptide SA-4 a high concentration verge was obligatory to exhibit membrane translocation though membrane perturbation was evident at lower concentrations.
All the peptides designed in the present study based on an amphipathic template of 12 residues showed potent antimicrobial activity against the bacterial strains tested except peptide SA-2. The observed decrease in antibacterial potency may be correlated with the decreased hydrophobicity of peptide SA-2 resulting from removal of Trp residue at third position and a loss of secondary structure acquisition tendency in membrane bound state due to incorporation of Pro residue. Trp residue which has a tendency to position itself at the interface between the lipid layer and the polar head groups has been reported to enhance membrane interactions and thus we observed a deleterious effect of replacing Trp with Pro residue on antimicrobial activity and secondary structure acquisition tendency. In literature also it has been reported that placement of certain Trp residues at key positions can be crucial for better antimicrobial potency [34] . Trp-rich peptides are more potent at membrane interaction was further corroborated by potent activity of Trp-rich peptides SA-3, SA-5 and SA-6 designed in the study.
CAMPs have gained much attention in the past decade because of their rapid killing mechanism and wide spectrum of activity against bacteria, fungi, virus, protozoa and cancerous cell. Bactericidal kinetics data of the peptides indicated that at 2 × MIC peptides SA-1, SA-3 and SA-4 were able to cause significant damages to E. coli and S. aureus cells within 15 min of incubation ( Fig. 1) . Comparison of Proteinase-K stability data based on RPHPLC of peptide SA-1 and SA-4 showed better in vitro stability for Orn containing peptide SA-4 as compared to SA-1 (Fig. 3) .
For systematic use as a therapeutic agent it is important to develop potent CAMPs with less toxicity against host cells. In our study hemolytic activity as a measure of host cell toxicity showed that out of the six peptides designed peptide SA-1 was found to be hemolytic against hRBC. Interestingly in peptide SA-4 where all Lys residues of peptide SA-1 have been replaced with Orn residues exhibited negligible hemolytic activity. As the two peptides SA-1 and SA-4 differ only in the depth of their polar sector, determined by length of the side chain of charged polar residues Orn and Lys, in concord with earlier literature we propose better insertion of Lys containing peptide SA-1 into the hydrophobic bulk of hRBC that might lead to hemolytic activity. The better insertion/penetration depth of Lys containing 
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peptides in comparison to Orn containing peptides has been correlated with snorkling effect whereby longer side chain of Lys residues tend to stretch towards the membrane interface thus leading to deeper penetration in the membrane bilayer [35] . The better membrane interactions of peptide SA-1 were also evident from CD spectra of the two peptides where the induced helical structure was much pronounced for peptide SA-1 as compared to peptide SA-4. Peptide SA-3 and SA-5 were relatively less effective at perturbing hRBCs both showing negligible hemolytic activity. On comparing Orn containing peptides SA-4 and SA-5 it was observed that both the peptides exhibit a shallow insertion into human erythrocytes which was reflected by their low hemolytic activity however the better potency of peptide SA-5 in comparison to SA-4 can be ascribed to presence of multiple Trp residues. Peptide SA-6 (acetylated analogue of peptide SA-3) exhibited 30% hemolytic activity at 512 μg/ml (Fig. 2) . The probable explanation for this increase in hemolytic behavior of peptide SA-6 can be accounted by taking into consideration the fact that acetylation of N-terminus removes one unit positive charge from the N-terminal of the peptide SA-6 altering the positive charge distribution of peptide SA-6 in such a way that might facilitate better folding and penetration of Trp residue at position 3 into the hydrophobic bulk of zwitterionic membranes. This induced folding would allow peptide SA-6 to better assume a wedge like structure as has been observed in the present study and has also been reported for Trp-rich peptides indolicidin and tritripticin [27] . Further tryptophan fluorescence studies substantiated the membrane discriminatory activities of the designed peptides on model membranes. A blue shift in the emission maxima of Trp residues suggests insertion of Trp residues into the hydrophobic environment of bacterial mimic membrane resulting because of preference of Trp residue to locate itself at membrane interface rather than in aqueous environment. As compared to buffer, large blue shift values for emission maxima of Trp residue were observed for all six peptides in bacterial mimic membranes (DPPC:DPPG, 7:3, w/w) ( Table 3 ). The maximum blue shift observed for peptide SA-1 indicated maximum burial of Trp residue of peptide SA-1 into the core of bacterial mimic membranes. The relatively lower blue shift observed can be ascribed to presence of multiple Trp residues in these peptides [36] . On comparing environment of Trp residues in Trp-rich peptides SA-3, SA-5 and SA-6, though almost comparable blue shifts were observed in the range of 14-16 nm, the relative order of quantum yield for the peptides in bacterial mimic membrane was SA-3 N SA-6N N SA-5 whereas in mammalian mimic membrane the order was altered to SA-6 N SA-3N N SA-5 (data not presented here). These results are indicative of a more restricted environment of Trp residues in mammalian mimic membrane for peptide SA-6 that accounts for the slight toxicity of peptide SA-6. In mammalian mimic membrane (DPPC: Chol) lesser blue shift was observed for all the peptides. The lesser blue shift observed (3-10 nm) for all six peptides in mammalian mimic membrane (DPPC: Chol) can be accounted by taking into consideration the lesser preference of Trp residue (of the cationic peptide) to insert into zwitterionic DPPC membrane which gets further rigidified upon inclusion of cholesterol. It has been reported that cholesterol causes a reduction of the density of the head group in DPPC at the interfacial region of the bilayer and an increase in the package of the phospholipid tails in the middle of the bilayer making insertion of Trp residue less likely [37] . CD spectra of peptides SA-1 and SA-4 in bacterial mimic LUVs showed a propensity to acquire helical conformation whereas peptides SA-2 also exhibited some ordering in TFE and bacterial mimic LUVs. Peptide SA-3, SA-5 and SA-6 were practically devoid of helical propensity due to presence of two adjacent Trp residues at 7 and 8 positions. For these three peptides SA-3, SA-5 and SA-6 the minima at 226-232 nm has typically been assigned to Trp-Trp stacking in small peptides [38] . In addition for peptide SA-6 positive bands at 222, 217 and 212 indicated a turn structure for peptide SA-6. Although CD data are not sufficient to comment on the secondary structure but in analogy to other Trp-rich CAMPs (like Indolicidin and tritripticin) maybe the peptide SA-6 adopts an extended turn structure in membrane mimic environment as has been characterized by a minima at 228 nm for tritripticin which binds the membranes in a wedge like manner. [27] (Fig. 4) .
Like many other membrane permeabilizing CAMPs such as LL-37 and melittin peptides designed in the present study showed a graded release of encapsulated fluorescent dye calcein [39, 40] . Only partial leakage of vesicle contents caused by peptides SA-3 and SA-4 can be justified based on graded leakage mechanism which is suggestive of the fact that the peptides might have pore formation as a subsidiary mode of action and the leakage observed was actually a result of mass imbalance caused by binding of the peptide to the membrane. As soon as the peptide translocation is over the transient pore formed gets closed and no further leakage is observed [41] . Peptide SA-1 with better membrane binding abilities started the interaction/translocation at low concentration whereas for peptide SA-4 a concentration threshold was required to induce leakage and translocation. We further carried out TEM study using bacterial mimic LUVs to gain visual evidences for membrane lipid interactions. In earlier TEM reports on various CAMPs, peptides induced aggregation or deformation of vesicles has been reported as a result of peptide lipid interactions [42] . We observed a smooth spherical lipidic vessel that gets distorted as a result of peptide lipid interactions. For peptide SA-3 we could visualize transient openings that could have been created in the spherical LUVs as a result of peptide translocation across the bilayer. For peptide SA-4 no such openings in the LUVs were observed however surface distortion of liposome from the normal rounded morphology could be visualized (Fig. 6) .
Microscopic techniques such as SEM, TEM and AFM have been used extensively for the elucidation of interaction of membrane active peptides [43, 44] . Based on different mode of cell perturbation observed under electron microscope different modes of action has been proposed for peptides with dissimilar structural preferences [45] .
SEM studies conducted with peptide SA-3 and SA-4 exhibited different patterns of morphological effects caused by the peptides on E. coli (Fig. 7) . Within 30 min of incubation peptide SA-3 at 10 × MIC was able to perforate E. Coli cells whereas peptide SA-4 like many other surface active peptides such as melittin caused surface swelling and aggregation in E. coli cells [46] . The micrographs of peptide treated E. coli cell makes it clear that the two peptides SA-3 and SA-4 act differently on model bacterial mimic membranes ( as evidenced by dye leakage assay) as well as on intact E. coli ATCC 11775.
Further in confocal laser scanning microscopy at low concentration we observed translocation of peptide SA-3 across the membrane in a non-membrane disruptive manner as has been observed for peptides which operate by intracellular targeting such as buforins [47] . However at the same concentration peptide SA-4 lysed E. coli cells to death without entering into the cytoplasm as could be visualized in differential contrast images (DIC) Fig. 8D . At a higher concentration of 10 μg/ml internalization of FITC-tagged peptide SA-3 lead to concomitant membrane damage. At the same concentration peptide FITC-SA-4 also traversed the bacterial membrane, again causing membrane rupture and formation of membrane debris (Fig. 8) . Similar to our results, in another study on interaction between magainin 2 and CHO-K1 cells, cell translocation concomitant with cell perturbation has been reported as the mode of action for the peptide [48] .
With flow cytometric data ( Fig. 9) we gained a quantitative picture of concentration dependent internalization and membrane damage potential of peptide SA-3 and SA-4 into the cytoplasm of E. coli ATCC 11775. In comparison to confocal data in our flow cytometry data of peptides with non-cell permeant dye PI a more pronounced concentration dependent increase in fluorescence was observed for peptide SA-3, which can be ascribed to its better potency and rapid bactericidal kinetics against E. coli.
The PI uptake assay further potentiates the rapid membrane translocation ability of peptide SA-3 which leads to formation of PI-DNA complex quantitatively at higher concentration. However peptide SA-4 was unable to cause significant damages to bacterial cell to reach intracellular DNA over the period of 15 min under the experimental conditions.
The non-cell perturbing internalization tendency of peptide SA-3 prompted us to look for some intracellular targeting mode of action for this peptide. With this aim we compared the relative affinity of peptides SA-3 and SA-4 to bind plasmid DNA (Fig. 10) . In concord with our confocal microscopy data, in DNA binding assay for peptide SA-3 and SA-4 a preferential DNA binding affinity of peptide SA-3 was observed which was reflected as retardation in the movement of plasmid DNA. Comparative binding assay revealed a higher affinity of peptide SA-3 for plasmid DNA which is suggestive of the probable role of intracellular targeting as an alternative mode of bacterial killing activity for the peptide. For indolicidin though complete retardation was not observed at concentrations tested, a concentration dependent retardation in movement of DNA was observed. The results suggest better binding of DNA with peptide SA-3 as compared to peptide SA-4 and indolicidin.
Current study on short, amphipathic template based CAMPs afford us two lead peptides SA-3 and SA-4 with potent activity against susceptible as well as multi-drug-resistant bacterial strains and negligible hemolytic activity. Based on the results of all the biophysical and microscopic data on peptide SA-3 and SA-4 we propose intracellular targeting as primary mode of action for peptide SA-3 whereas peptide SA-4 was more prone to membrane damage mode of action. It has been well reported in the literature that Trp content and position of Trp residue in a peptide can alter its mode of interaction with the bacterial membrane [49] . On similar lines we propose that presence of 3 Trp residues in the hydrophobic sector of the amphipathic template of peptide SA-3 makes it more prone to insert and translocation into the membrane of E. coli ATCC 11775 as compared to peptide SA-4 which although has the same number of hydrophobic residues but was lacking Trp residues at position 7 and 8 in the sequence. Membrane translocation and concentration dependent membrane damage caused by these two peptides do not however precludes them for other mechanism of action on different bacterial cells however a distinction in the mode of cell permeation against E. coli ATCC 11775 has been ascertained by the data presented in the study. Further it would be interesting to study interactions of the designed peptides with representative Gram-positive bacteria such as S. aureus. In conclusion with different mode of cell perturbation peptide SA-3 and SA-4 designed in the present study can be further optimized for use in clinics. Cell selective, naturally occurring, host defence cationic peptides present a good template for the design of novel peptides with the aim of achieving a short length with improved antimicrobial potency and selectivity. A novel, short peptide CS-1a (14 residues) was derived using a sequence hybridization approach on sarcotoxin I (39 residues) and cecropin B (35 residues). The sequence of CS-1a was rearranged to enhance amphipathicity with the help of a Schiffer-Edmundson diagram to obtain CS-2a. Both peptides showed good antibacterial activity in the concentration range 4-16 lgÁmL À1 against susceptible as well as drug-resistant bacterial strains, including the clinically relevant pathogens Acenatobacter sp. and methicillin-resistant Staphylococcus aureus. The major thrust of these peptides is their nonhaemolytic activity against human red blood cells up to a high concentration of 512 lgÁmL
À1
. Compared to CS-1a, amphipathic peptide CS-2a showed a more pronounced a-helical conformation, along with a better membrane insertion depth in bacterial mimic 1,2-dipalmitoylsn-glycero-3-phosphocholine/1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) small unilamellar vesicles. With equivalent lipid-binding affinity, the two peptides assumed different pathways of membrane disruption, as demonstrated by calcein leakage and the results of transmission electron microscopy on model bacterial mimic large unilamellar vesicles. Extending the work from model membranes to intact Escherichia coli cells, differences in membrane perturbation were visible in microscopic images of peptide-treated E. coli. The present study describes two novel short peptides with potent activity, cell selectivity and divergent modes of action that will aid in the future design of peptides with better therapeutic potential.
Introduction
With a broad range of activity against bacterial strains, fungi, viruses and even cancerous cells, host defence cationic peptides (HDCPs) are considered as impending drug candidates for combating a variety of microbial infections [1, 2] . The widespread distribution of HDCPs in all forms of life, from simple unicellular Abbreviations ATCC, American Type Culture Collection; CFU, colony-forming units; FITC, fluorescein isothiocyanate; HDCP, host defence cationic peptide; hRBC, human red blood cell; IL, indolicidin; LUV, large unilamellar vesicle; MDR, multidrug resistant; MHB, Mueller Hinton broth; MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus; PC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; PDI, polydispersity index; PG, 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt); SEM, scanning electron microscopy; SUV, small unilamellar vesicle; TEM, transmission electron microscopy; TFA, trifluoroacetic acid; TFE, trifluoroethanol. bacteria to complex multicellular humans, and the preservation of these peptides throughout evolution points out to their importance as molecular weapons in the first line of defence [3] . HDCPs have a multifaceted role in innate immunity, including lipopolysaccharide neutralization, wound and burn healing, and direct microbicidal killing activity [4] . In multicellular organisms, different structural classes of HDCPs with varying amino acid sequences ensure an effective innate immune response upon microbial invasion [5, 6] . It would be difficult for microorganisms to develop resistance against HDCPs because of a cell lytic mode of action, where HDCPs are able to perturb the bacterial membrane rather than employ a specific receptormediated mode of action [7] . During the last decade, renewed attention on peptide antibiotics has been observed as a result of the emergence of multidrug resistant (MDR) bacterial strains in hospitals and communities [8, 9] . Currently, robust efforts are being made to design better peptides/peptidomimics as therapeutic agents against MDR bacterial strains [10, 11] .
The characteristic features of positive charge and hydrophobicity facilitate the incorporation of HDCPs into the bacterial membrane, which subsequently may lead to clean transportation into the cells (intracellular targeting) or cause membrane disruption in the form of pores [12, 13] . Based on peptide-lipid interactions, various modes of action have been proposed for membrane disruptive peptides, such as the barrel stave model, the carpet model and the recently proposed charge cluster mechanism, where an initial electrostatic interaction between cationic peptides and the negatively-charged bacterial membrane was shown to play a crucial role [14, 15] .
Sequence abstraction and hybridization of HDCPs represents a flourishing approach for the design of short and potent peptides with improved physiological characteristics [16] [17] [18] . The parent peptides cecropin B and sarcotoxin, as used in the present study, were identified as defence proteins in insects. Cecropin B was first isolated from the haemolymph of the Chinese oak silk moth, Anthevaea pernyi, whereas sarcotoxins were first isolated from the flesh fly, Sarcophega peregrana [19, 20] . Having a positive charge and the ability to acquire helical conformation in the membrane environment, these peptides can interact with lipopolysaccharides and other negatively-charged lipids in bacterial cells to cause leakiness followed by cell death [21, 22] .
In the present study, using the sequence hybridization approach, we designed and synthesized a short and potent 14-residue peptide CS-1a amidated at the C-terminal. The sequence rearranged analogue of CS-1a was designed by increasing the hydrophobic moment, resulting in peptide CS-2a. We established the potent antibacterial activity and nontoxic nature of both peptides towards human red blood cells (hRBCs). To characterize and compare the membrane interactions of CS-1a and CS-2a in terms of structuring, insertion depth, lipid-binding and membrane pore-forming abilities, biophysical experiments on model membranes were performed and complimented by intact cell studies. Interaction studies on CS-1a and CS-2a establish the distinct membrane active mode of action assumed by these peptides and aid in the future design of short, potent and cell-selective antimicrobial peptides.
Results
Peptide design
A short hybrid peptide CS-1a was designed based on sarcotoxin and cecropin B as parent peptides. In the sequence of CS-1a, the first seven residues of sarcotoxin (GWLKKIGKKIERVGQHTRDATIQGLGIAQQ AANVAATAR-NH 2 ; 39 mer) were linked with the first seven residues of cecropin B (KWKIFKKIEKV GRNIRNGIIKAGPAVAVLGEAKAL-NH 2 ; 35 mer). The rationale behind our design was that the N-terminal region of both parent peptides is rich in positivelycharged amino acid residues. Previous studies also indicated the importance of N-terminal residues in cecropin B and sarcotoxin with respect to their potent antimicrobial activity [23, 24] . CS-1a (GWLKKIG-KWKIFKK-NH 2 ) with a +7 charge and having exactly 50% hydrophobic amino acid residues could represent a candidate antibacterial peptide (Table 1) . To the best of our knowledge, hybrid peptides derived from sarcotoxin -cecropin B have never been reported previously. Because amphipathicity has also been used as a primary determinant for antimicrobial activity [25] , peptide CS-2a was generated by rearranging the sequence of CS1a with the help of a Schiffer-Edmundson diagram (Fig. 1) . HYDROMCALC software (www.bbcm.univ.trieste. it/~tossi/HydroCalc/HydroMCalc.html) predicted the mean hydrophobic moment <l> for CS-1a as an a-helix as 0.05 compared to 0.44 for CS-2a on Eisenberg's hydrophobicity scale [26] . To further assess the effects of C-terminal amidation on antimicrobial activity and for conformation of the peptides, the corresponding C-terminal acids were also synthesized.
Antibacterial and haemolytic activities of the designed peptides
Peptides CS-1a and CS-2a showed good activity against Gram-positive and Gram-negative bacterial 
À1
. The C-terminal acid analogues of both peptides showed relatively lower activity in the range 8-128 lgÁmL À1 . The importance of C-terminal amidation for the activity of short antimicrobial peptides has been described previously [27] . For comparison of antibacterial activity, one of the parent peptides cecropin B, another host defence peptide indolicidin and polymyxin B were also assayed. The activity ranges for these peptides were 3-128 lgÁmL À1 for cecropin B and 16-64 lgÁmL À1 for indolicidin. Polymyxin B showed excellent activity against Gram-negative cells; however, against Grampositive Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), the activity was lower compared to the designed peptides.
It is important to note that, similar to cecropin B, CS-1a, CS-1 and CS-2 were found to be nonhaemolytic up to a concentration of 512 lgÁmL À1 (Table 2) . CS-2a exhibited 28% haemolysis at 512 lgÁmL À1 . Indolicidin was found to cause haemolysis from a low concentration of 64 lgÁmL À1 causing 87% lysis at 512 lgÁmL À1 .
Structural transitions and insertion depth in artificial membranes
The CD spectra of the designed sequences were acquired in various environments, including 5 mM phosphate buffer, helix-inducing solvent trifluoroethanol (TFE) (50%, v/v), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine/1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (PC/PG) (7 : 3, w/w) large unilamellar vesicles 
CS-1a
CS-2a (LUVs) as bacterial mimic and PC LUVs as mammalian mimic membranes. All peptides were unstructured in buffer with minima at 202 nm ( Fig. 2A) . Peptides CS-1a and CS-2a acquired a defined helical conformation in helix-inducing solvent TFE with double minima at 208 and 222 nm (Fig. 2B) . CS-1 in TFE showed double minima in the spectrum; however, the positions of the minimum were 206 and 218 nm, which are slightly displaced from the normal helical signature bands. Peptide CS-2 in TFE exhibited an unordered conformation, showing a broad minimum at 205 nm. In bacterial mimic LUVs, CS-1a, CS-2a and CS-2 showed a helical conformation. CS-2a exhibited the most well defined conformation, with a relatively enhanced signal intensity (Fig. 2C ) in bacterial mimic LUVs. All four peptides remained unstructured in mammalian mimic PC LUVs, with minima at 202 nm (data not shown).
In a Trp fluorescence experiment in Tris buffer, all four designed peptides and indolicidin exhibited emission maxima at either 358 or 359 nm, which is typical for Trp residues in a polar environment. Compared to buffer, in SUVs mimicking bacterial membranes, appreciable blue shifts were observed in the emission maxima of Trp residues in the order CS-2a (22 nm) > CS-1a (16 nm) > CS-2 (14 nm) > Indolicidin (13 nm) > CS-1 (12 nm), concomitant with an almost four-fold increase in emission intensity for all five peptides. In PC SUVs, only CS-2a and indolicidin showed an appreciable shift of 5 and 6 nm, respectively, with only minimal changes in emission intensity.
Comparison of peptide binding and pore-forming abilities on PC/PG model membranes
For the lipid-binding experiment, a shift in emission maxima, as well as a quantum yield of Trp residues, was followed by incubating a fixed concentration of peptide with an increasing concentration of PC/PG SUVs (Fig. 3) . Indolicidin with a well defined mode of action was used as a control peptide. The first addition of PC/PG SUVs (85 lM) to peptides in Tris buffer resulted in a blue shift of 8, 12 and 7 nm for CS-1a, CS-2a and indolicidin, respectively. The second addition of PC/PG SUVs (340 lM) induced significant changes in the emission maxima and, at a still higher concentration of lipid, all three peptides achieved a plateau of saturation in blue shift (Fig. 3A) . In PC SUVs, the maximum shift in emission wavelength was observed at a lipid concentration of 748 lM, where CS-1a, CS-2a and indolicidin caused a blue shift of 11, 6 and 8 nm, respectively (Fig. 3B) . At a higher PC concentration, insignificant changes were observed in blue shift for all three peptides compared to at a lipid concentration of 748 lM. The addition of an increasing concentration of PC SUVs to peptides resulted in a blue shift, although the extent of the shift was low compared to the shift caused by the addition of PC/PG SUVs. Furthermore, in the same experiment, using emission intensity, binding curves to PC/PG SUVs were obtained by plotting the fraction of bound peptide (F À F 0 /F max À F 0 ) versus SUV concentration (Fig. 3C) . The approximate binding constant obtained by fitting the data to a hyperbolic curve using ORIGIN software, version 7.0 (Microcal, Inc., Northampton, MA, USA) indicated the comparable binding of CS-1a compared to CS-2a, where the calculated binding constants were 2. [28] .
Trp quenching experiments using acryl amide as an aqueous quencher were performed to compare the Fig. 4 . The fluorescence intensity of Trp residues in CS-1a and CS-2a decreased upon the addition of quencher acryl amide in Tris buffer; however, the relative decrease was more evident in the case of CS-1a rather than CS-2a. This shows the partial screening of Trp residues in CS-2a from the quencher, which may be a result of the non-accessibility of Trp residues to acryl amide. The quenching efficiency was found to be in the order Tris > PC > PC/PG. Therefore, it was evident that Trp residues in these peptides are relatively free in buffer, show a weak interaction in PC SUVs and become deeply inserted into the PC/PG membrane core. In all three media, CS-2a showed a lower value Stern-Volmer constant compared to CS-1a.
In the calcein leakage assay, CS-1a caused a rapid increase in fluorescence intensity, leading to a 68% increase at 2.9 lgÁmL À1 , whereas CS-2a caused only a 19% increase relative to the intensity increase as a result of the addition of 20 lL of 10% TX-100 (Fig. 5) caused 48% leakage of encapsulated calcein, which is in accordance with the low leakage ability of the peptide reported previously [29] . 
as ( ) CS-1a, (□) CS-2a and (■) IL. The fitted curves are presented as ( ) CS-1a, (---) CS-2a and (---)
IL. Fluorescence spectra were recorded at 25°C by exciting samples at 280 nm and recording emission from 300 nm to 400 nm. A slit width of 5 nm was used for both excitation and emission. Contributions from the buffer and SUVs were subtracted from the experimental spectrum. 
Microscopic analysis of vesicle fusion/disruption by peptides CS-1a and CS-2a
The perfectly circular shape of freely dispersed PC/PG liposome could be visualized under a transmission electron microscope (Fig. 6A) . Upon peptide treatment, for CS-1a, broken or clustered vesicles with altered morphologies were evident with disrupted liposomal linings spread over the entire surface (Fig. 6B, arrows) . For CS-2a, small electron dense structures were observed at the outer lining, which were assumed to be peptide-rich clusters formed upon peptide-lipid interactions (Fig. 6C, arrows) .
Visualization of interaction of peptides with intact E. coli ATTC 11775
At the MIC, surface perturbation in the form of blebs was apparent in the scanning electron microscopy (SEM) micrograph of CS-1a-treated cells (Fig. 7B) . For CS-2a, cells exhibited disrupted flattened ends at the MIC (Fig. 7C, arrows) . Many significant alterations in the form of surface swelling of the bacterial membrane, along with cell debris, were observed for CS-1a at concentration corresponding to 10 9 MIC (Fig. 7D) . At 10 9 MIC, bacterial cell clusters for CS2a with disrupted apical cell ends were again prominent (Fig. 7E, arrows) .
Localization in E. coli ATCC 11775 and comparative DNA-binding ability
To study the localization of peptides in E. coli, we made use of fluorescein isothiocyanate (FITC)-tagged peptides CS-1a and CS-2a (almost equivalent antimicrobial activity was observed for the FITC-tagged peptides, Table S1 ). Confocal images at the MIC revealed the translocation of FITC-CS-1a into the cytoplasm of E. coli without much membrane perturbation (Fig. 8B) . For FITC-CS-2a, a weak green fluorescence signal was observed, which indicated the relatively poor internalization tendency of this peptide (Fig. 8C) . At 4 9 MIC, both peptides showed appreciable membrane disruption along with cellular accumulation in the cell cytoplasm (Fig. 8D, E) .
In a DNA-binding assay, CS-1a caused a retardation in the movement of DNA at 4 lgÁmL
À1
, whereas CS-2a showed binding at a two-fold higher concentration of 8 lgÁmL À1 (Fig. 9) . The DNA-binding ability of indolicidin was also assayed and, in accordance with a previous study [30] , it was unable to bind to DNA at the maximum concentration tested of 8 lgÁmL À1 .
Discussion
Various structure-activity relationship studies have reported that certain stretches of amino acid residues with positively-charged and hydrophobic side chains impart potent antibacterial activity and cell selectivity to antimicrobial peptides [31, 32] . The reported synergistic activity among different HDCPs also suggests that the design of hybrid peptides using active sequences from different parent peptides may lead to shorter and more potent peptides with activity against MDR bacterial strains, which is a present need [33] . Therefore, the design of shorter peptides based on a hybrid peptide approach is currently being explored. In the present study, hybrid peptide CS-1a was derived from the sequences of a-helical insect HDCPs sarcotoxin and cecropin B. Without altering the physiochemical parameters of CS-1a, such as length, charge and hydrophobicity, we simply rearranged the sequence to obtain a more amphipathic peptide CS-2a with the help of a Schiffer-Edmundson diagram (Fig. 1) . With an almost three-fold reduction in length compared to one of the parent peptides, cecropin B, hybrid peptide CS-1a exhibited comparable or better antibacterial potency (except for activity against E. coli). Amphipathic peptide CS-2a was found to be two-to 16-fold more active compared to cecropin B (Table 2) . CS-2a exhibited a four-fold higher potency against MRSA compared to standard antibiotic polymyxin B. The major thrust of the designed peptides is (a) their small size, which makes them more viable therapeutically (i.e. low immunogenicity and cost effective), (b) an ability to kill the clinically relevant pathogens Acenatobacter sp. and MRSA and (c) nonhaemolytic behaviour towards hRBCs up to very high concentration of 512 lgÁmL À1 . To obtain better insight into the mode of action of these active sequences, we compared the interactions of CS-1a and CS-2a on model bacterial mimic and mammalian mimic membranes, as well as intact bacterial cells.
To target bacterial membranes as their prime interaction site, peptide folding into helices or pleated sheets in the vicinity of model membranes has been reported to be crucial for understanding the structuredependent mode of action for a number of short peptides [34, 35] . The conformational transitions for CS-1a and CS-2a, from unordered in buffer to a-helical in PC/PG LUVs, indicate the importance of hydrophobic moment for acquiring helical structure, which, in turn, is also related to antibacterial activity. C-terminal acid analogues CS-1 and CS-2 with same charge (+6) showed a difference with respect to helical propensity in PC/PG LUVs, which might have resulted in a relatively weaker antibacterial activity for CS-1 ( Fig. 2 and Table 2 ). A difference in antibacterial activity between the C-terminal amide and acid attributable to the acquisition of better helical structure upon membrane binding has previously been reported for 16 amino acids containing modelin-5 peptide [36] .
Furthermore, CS-2a, with a better propensity to acquire helical conformation in PC/PG LUVs, could insert deeper into the membrane hydrophobic core, as was evident from the maximum change in blue shift (22 nm) observed for the Trp residues of this peptide ( Fig. 2C and Table 3 ). CS-1a was unable to insert deep into PC/PG SUVs, showing a blue shift of 16 nm. Thus, it may be inferred that the enhanced helicity of CS-2a assisted with its deeper insertion into PC/PG SUVs, whereas CS-1a has comparatively weak interactions with bacterial mimic SUVs. In accordance with their structure-acquiring potential in PC/PG SUVs, the three designed peptides, CS-1a, CS-1 and CS-2, showed a shallower insertion into the membrane bilayer core, as evident from the Trp emission maxima data for these peptides (Table 3) . In PC SUVs, a very low blue shift for all peptides further indicated the superficial interaction of peptides with zwitterionic PC membranes at the lipid concentration tested. The Trp fluorescence data thus corroborate the cell selective nature of the designed peptides because all of them showed preferential insertion into PC/PG SUVs compared to PC SUVs.
Based on activity and CD data, we further compared the mode of action of the more active amidated analogues CS-1a and CS-2a. An induced secondary structure plays a key role in the binding and insertion of HDCPs into bacterial cells or model membranes. Interestingly, although CS-2a had a much better structuring propensity compared to CS-1a, the binding to PC/PG SUVs (i.e. in terms of a change in emission intensity) was not influenced much by the structure (Fig. 3C ) and the approximate binding constants were Fig. 9 . Gel retardation assay. Binding was assayed by the inhibitory effect of peptides on the migration of DNA bands. Various amounts of peptides were incubated with 100 ng of plasmid DNA at room temperature for 1 h and the reaction mixtures were applied to 1% agarose gel electrophoresis. Lane [37] . Although CS-2a is more active than CS-1a, the calcein leakage assay showed CS-1a to be a better pore former (Fig. 5) . For CS-2a at higher concentrations, an increase in peptide-mediated leakage was observed, although complete leakage of vesicle content was never observed. Low leakage of vesicle content as a result of peptide aggregation at a high peptide : lipid ratio in a bacterial mimic artificial liposome has also been reported previously for esculentin-1b peptide [38] . To understand the low leakage-causing ability of CS-2a, we attempted to visualize vesicle damage and/or the aggregation-causing ability of the two peptides.
To study peptide-lipid interactions, the use of TEM is considered as a suitable method for determining the membrane active mode for action with respect to various antimicrobial peptides [39, 40] . The TEM results for CS-2a showed an even spreading of the peptide at the outer lining of the vesicles, leading to the formation of peptide-rich clusters (Fig. 6C) . These tiny clusters might be inferred to occur as a result of aggregation of peptide in the vicinity of model membranes. For relatively shorter peptides with 14 residues, aggregation in buffer may not be a spontaneous event; amphipathic peptides with hydrophobic (sticky) patches may tend to aggregate in the vicinity of membranes as a result of their better partition coefficients in membranes compared to buffer [41] . The CD data for CS-2a showed H 222 /H 208 to be 1.88 in PC/PG LUVs, which, when > 1, is indicative of interacting helices, as reported previously [42] . Therefore, it is plausible for peptide CS-2a to aggregate in the vicinity of PC/PG LUVs. The accumulation of Sushi-derived amphipathic MIRIAM peptide and cell penetrating S4 13 -PV peptide after nanogold tagging in the vicinity of E. coli and HeLa cells, respectively, was also observed as a step occurring before cell death and cell penetration, respectively [43, 44] .
To probe this possibility for CS-2a on intact E. coli, we further carried out SEM. In SEM, a clear distinction in the patterns of surface alteration caused by the two peptides was evident (Fig. 7D, E) . Even surface-bound vesiculation at the MIC and 10 9 MIC was observed for CS-1a, whereas, for CS-2a, disrupted apical ends of the cells were more prominent (Fig. 7E) . Interaction studies of magainin 2 and Sushi-derived antimicrobial peptides with E. coli also showed apical end damage as a major effect, which was correlated with the presence of cardiolipin-rich regions at the ends of the bacterial cells [45] [46] [47] . Similarly, CS-2a might also be able to accumulate at the apical ends of the cells that are rich in cardiolipin and cause cell disruption, thus resulting in potent activity at low concentrations.
Using live cell confocal microscopy, we could detect localization of FITC-CS-1a into the cytoplasm of E. coli, making it appear bright green at the MIC (Fig. 8B) . For FITC-CS-2a, fluorescence spread was visible in the cell, although it was weak compared to CS-1a (Fig. 8C) . In a gel retardation assay, the positively-charged nature of both peptides might allow them to interact with DNA in a nonspecific manner, although we observed a better binding for CS-1a, which may indicate a diversified mode of action for CS-1a (Fig. 9) . A DNA-binding ability along with a low structuring tendency has previously been reported for proline-containing model amphipathic peptides with an established membrane translocating mode of action [48] . A lower cell penetration ability, as well as an increased cytotoxicity of amphipathic, self-associating peptides, has also been reported prevously in the literature [49] .
Overall, after obtaining potent, cell selective antibacterial peptides in an attempt to delineate the role of sequence rearrangement on modes of action, we conclude:
• An equal charge on CS-1a and CS-2a leads to equivalent initial electrostatic interactions, as indicated by similar binding constants. However, after initial binding for the second step of membrane insertion, a better structure acquisition potential of CS-2a lead to its deeper insertion in the hydrophobic bulk of artificial membranes, as indicated in the Trp fluorescence quenching experiment.
• A lower helical content, less insertion, an enhanced pore-forming ability and a better DNA retardation tendency of CS-1a lead to its cleaner internalization into the bacterial cells at a low concentration, although, at higher concentrations, it causes severe membrane perturbation. CS-2a showed a vesicle aggregation tendency in artificial membranes, which correlated with its membrane tearing-off potential after accumulation at apical ends of E. coli. Poor cellular internalization in E. coli along with relatively weaker DNA-binding suggests a predominant membrane disrupting mode of action for this peptide.
In conclusion, the present study adds to the repertoire of potent cell selective antibacterial peptides with a broad range of activity against the clinically relevant pathogens Acenatobacter sp. and MRSA along with cell selectivity. The biophysical and microscopic evidence demonstrates the advantages of designing peptides with slightly discontinuous hydrophobic and charged sectors with the aim of diminishing the aggressive integration of peptides into bacterial/mammalian cells and minimizing eukaryotic toxicity. Therefore, the present study provides both biophysical and visual mechanistic evidence that will aid in the design of peptide analogues with better therapeutic potential.
Materials and methods
Chemicals
Fluorenylmethoxycarbonyl-protected amino acids and resins were purchased from Novabiochem (Darmstadt, Germany). Piperidine, N-hydroxybenzotrizole, TFE, trifluoroacetic acid (TFA), dimethlyaminopyridine, diisopropylethylamine, N-methyl pyrrolidinone, N,N-diisopropylcarbodiimide, triisopropylsilane, FITC, calcein and cholesterol were purchased from Sigma Chemical Co. (St Louis, MO, USA). PC and PG (sodium salt) were purchased from Avanti Polar Lipids (USA). Cecropin B was purchased from Anaspec (San Jose, CA, USA) with an analytical purity > 95%. All solvents used for the purification were of HPLC grade and obtained from Merck (Darmstadt, Germany). Dimethylformamide and dichloromethane were obtained from Merck (Mumbai, India). Dimethylformamide was double-distilled before use.
Peptide synthesis and purification
All peptides were synthesized using an automated peptide synthesizer (Advanced Chemtech, Lousville, KY, USA) in accordance with standard fluorenylmethoxycarbonyl-solid phase protocols using Wang resin (loading 0.80 mMÁg À1 )
for peptide acids and Rink amide MBHA resin [Novabiochem, Darmstadt, Germany (loading 0.56 mMÁg
À1
)] for peptide amides as solid support, as described previously [50, 51] . FITC labelling was performed at the N-terminal of the peptides on solid support after elongation of the complete peptide chain with b-alanine at the N-terminus. For FITC tagging, four equivalents of FITC in dimethylformamide were added to the solid support (with deprotected NH 2 of b-alanine) with four equivalents of diisopropylethylamine as base [52] . The reaction was run overnight under inert atmosphere. A routine cleavage procedure using a mixture of trifluoroacetic acid, triisopropylsilane, phenol and water (95 : 2 : 2 : 1) for 3 h was employed for all peptides. The ESI-MS spectra of FITC-tagged peptides is provided in supplimentary data as Fig. S1 and Fig. S2 .
Purification of the peptides was performed on C-18 preparative RP-HPLC column (7.8 9 300 mm, 125 Å , 10-lm particle size) with linear gradients of water containing 0.05% TFA (gradient A) and acetonitrile containing 0.05% TFA 
Antibacterial activity
Antimicrobial susceptibility testing was carried out using a modification of the Clinical Laboratory Standard Institute microbroth dilution assay, as described previously [51, 53] . Briefly, the inoculums were prepared from mid-log phase bacterial cultures. Each well of 96-well polypropylene microtitre plate (Sigma) was inoculated with 90 lL of approximately 2 9 10 5 CFUÁmL À1 of bacterial suspension per millilitre of MHB (Difco). Then, 10 lL of serially-diluted peptides in 0.001% acetic acid and 0.2% BSA (Sigma) was added to the wells of the microtitre plate to achieve concentrations in a range from 256 lgÁmL À1 to 2 lgÁmL
À1
. The plates were incubated at 37°C with agitation. After 18 h, A 630 was monitored. Cultures (approximately 2 9 10 5 CFUÁmL À1 ) without peptide were used as a positive control. Uninoculated Mueller-Hinton broth was used as a negative control. The tests were carried out in duplicate on three different days. The MIC is defined as the lowest concentration of peptide that completely inhibits growth.
Haemolytic activity
The haemolytic activity of the peptides was determined using a 4% suspension of hRBC in NaCl/P i (35 mM phosphate buffer, 150 mM NaCl, pH 7.2), as described previously [48] . Percent haemolysis was calculated as:
where A is the absorbance of the peptide sample at 414 nm and A 0 and A t represent 0% and 100% haemolysis as determined in NaCl/P i and 1% Triton X-100, respectively. 
Preparation of LUVs for CD spectroscopy
LUVs were prepared as described previously [29, 51] . Briefly, desired mixtures of the lipids PC/PG or single component PC were dissolved in 2 mL of chloroform/methanol mixture in a 150-mL round-bottom flask. The solvent was removed under a stream of nitrogen and the thin lipid film obtained was lyophilized overnight to remove any traces of organic solvent. The lipid film was rehydrated with 5 mM sodium phosphate buffer (preheated at 60°C) vortex mixed for 30 min on a water bath kept above the phase transition temperature of the lipid mixture. The liposome suspension was freeze thawed for five cycles and extruded 16 times through two stacked polycarbonate filters (pore size of 100 nm). The mean diameter of LUVs was found to be in the range 95-110 nm as determined by dynamic light scattering on a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). The vesicles were used within the same day.
CD
CD spectra of peptides were recorded using a J-815 CD spectrophotometer (Jasco, Tokyo, Japan) with a 5-mm path length cell. Wavelengths in the range 190-260 nm were measured, with 1-nm step resolution, 100 nmÁmin À1 scan speed, 0.1-s response time and 1-nm bandwidth. CD spectra of peptides were collected and averaged over three scans in 5 mM sodium phosphate buffer (pH 7.2) in TFE (50% v/v), PC LUVs and PC/PG LUVs at 25°C. Spectra were baseline corrected by subtracting a blank spectrum of a sample containing all components except the peptide. For the experiment, different concentrations of peptides were mixed with PC/PG LUVs to obtain the optimum L : P ratio at which there was minimum signal loss as a result of excess light scattering because of peptide-mediated vesicle aggregation. The presented data were acquired at an L : P ratio of 34:1, corresponding to a peptide concentration of 20 lM and a lipid concentration of 680 lM. The experiment was repeated three times on three different days and found to be reproducible. Representative spectra after data smoothing are presented expressed as the ellipticity [H] versus the wavelength obtained from the instrument.
Trp fluorescence
The procedure used for the preparation of SUVs was similar to that described previously [48, 51] . Briefly, dry lipids PC/PG or PC were dissolved in a chloroform/methanol mixture in a 150-mL round bottom flask. Solvent was removed by a stream of nitrogen gas and the lipid film obtained was lyophilized overnight. Dried thin films were resuspended in 10 mM Tris buffer [0.1 mM EDTA and 150 mM NaCl (pH 7.4)] preheated to 60°C by vortex mixing. The lipid dispersions were then sonicated in ice for 15 -20 min using a titanium-tip ultrasonicator with a burst and halt time of 30 and 10 s until the solution became opalescent. Titanium debris was removed by centrifugation. For the Trp fluorescence experiment, each peptide (final concentration of 3 lM) was added to 500 lL of 10 mM Tris buffer (0.1 mM EDTA, 150 mM NaCl, pH 7.4) containing 300 lM SUVs. The peptide/SUVs mixture was allowed to interact at 25°C for 2 min. Fluorescence measurements were performed in a quartz cuvette with a 1-cm path length on a spectrofluorometer (Jobin Yvon FluoroMax 3; Horiba Scientific, Edison, NJ, USA). Samples were excited at 280 nm and emission was scanned from 300 to 400 nm at 1-nm increments. The excitation and emission slits were fixed at 5 nm. Spectra were corrected by blank subtraction for the contribution of light scattering by SUVs.
Lipid-binding experiment
For the lipid-binding experiment, different lipid concentrations of PC/PG SUVs (0, 85, 340, 680 and 1360 lM) or of PC SUVs (0, 83, 470, 748 and 1346 lM) were incubated with a fixed peptide concentration of 5 lM for 30 min as described previously [54] . Trp emission spectra were recorded using a 1-cm path length quartz cuvette on a spectrofluorometer (Jobin Yvon FluoroMax 3) with the excitation set at 280 nm using a slit width of 5 nm for both excitation and emission. Emission was scanned from 300 to 400 nm. Contributions from buffer and SUVs were subtracted from the experimental spectrum. Data are presented in the form of shift in emission maxima, as well as the binding curve. The binding curve was obtained by plotting the fraction of bound peptide (F À F 0 /F max À F 0 ) versus lipid concentration, where F is the fluorescence intensity of peptide at various lipid concentrations, F 0 is the intensity of peptide in buffer and F max is the intensity at maximum lipid concentration. The data were fitted to a hyperbolic curve using ORIGIN software, version 7.0, to obtain the binding constant. Changes in the emission maximum intensity at 338, 331 and 342 nm were used to draw binding curves for CS-1a, CS-2a and indolicidin, respectively. For mammalian mimic SUVs, the increase in emission intensity was not concentration-dependent; therefore, a proper binding curve could not be generated.
Trp fluorescence quenching
For the fluorescence quenching experiments, acryl amide was used as an aqueous quencher. Aliquots of the 4.0 M solution of this water-soluble quencher were added to different peptides in Tris buffer or in the presence of PC/PG SUVs or PC SUVs at an L : P molar ratio of 100 : 1. The acryl amide concentration in the cuvette was in the range 0.09-0.19 M. The effect of acryl amide on the fluorescence of each peptide was analyzed with a Stern-Volmer equation for collisional quenching:
where F 0 and F represent the fluorescence intensities of peptides in the absence and the presence of acrylamide, respectively, K sv is the Stern-Volmer quenching constant, and [Q] is concentration of acryl amide. Samples were excited at 295 nm with a slit width of 5 nm for both excitation and emission, and emission was monitored in the range 300-400 nm. The Stern-Volmer plots were drawn using intensity at emission maxima for different peptides. The experiment was repeated at least twice and the data are presented after linear fitting.
Calcein dye leakage assay
Leakage of calcein from bacterial mimic LUVs was studied as described previously [29, 51] . For the leakage experiment, LUVs were prepared as described for the CD experiment, except the rehydrating buffer, which comprised 10 mM Tris (70 mM calcein, 150 mM NaCl, 0.1 mM EDTA). After the addition of calcein, the pH of the LUVs mixture fall; to make it up to 7.2, a few drops of sodium hydroxide solution (1 M) were added. The liposome suspension was freeze thawed for five cycles and extruded 16 times through two stacked polycarbonate filters (pore size of 100 nm). Free calcein was removed by gel filtration on a Sephadex G-50 column at 25°C, eluting with a buffer of 10 mM Tris (150 mM NaCl, 0.1 mM EDTA). After gel filtration, the diameter of the liposome was measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments). The mean diameter of LUVs was found to be in the range 110-130 nm. Samples were excited at 490 nm and emission was monitored at 520 nm on a spectrofluorometer (Jobin Yvon FluoroMax 3). A slit width of 3 nm was used for both excitation and emission. Different concentrations of peptides were incubated with PC/PG LUVs for 5 min before exciting the samples. The percentage of dye leakage as a result of the peptides was calculated as:
where F is the fluorescence intensity achieved by the addition of different peptide concentrations, and F 0 and F t are the fluorescence intensities in buffer and with Triton X-100 (20 lL of 10% solution), respectively. All measurements were performed in duplicate and the data are presented as the mean ± SD. A phosphate assay was performed with the lipid mixture to determine the concentration for the leakage experiment [55] .
TEM
For TEM analysis, PC/PG LUVs were prepared in a similar fashion to that described for the CD experiment. Peptides CS-1a and CS-2a were incubated with LUVs at 25°C in 10 mM sodium phosphate buffer for 30 min. After incubation, the suspension was sonicated for 2 min on a bath sonicator and a drop was applied to glow-discharged carbon-coated copper grids for 1 min. The grids were blotted dry and stained with 2% phosphotungstaic acid for 30 s. Electron micrographs were then recorded using Morgagni 268(D) transmission electron microscope (FEI, Hillsboro, OR, USA) at an accelerating voltage of 70 kV.
SEM
For SEM, a method of sample preparation similar to that described previously [39, 51] was used. Briefly, E. coli was grown to mid log phase in MHB and harvested by centrifugation. After washing the pallet three times in NaCl/P i (35 mM phosphate buffer, 100 mM NaCl, pH 7.4), approximately 10 8 CFUÁmL À1 were resuspended in NaCl/Pi and incubated at 37°C with different peptide concentrations at the MIC and 10 9 MIC for 15 min. Controls were run in the absence of peptides. After 15 min, the cells were spun down, washed and fixed with an equal volume of 4% glutaraldehyde in 0.2 M Na-cacodylate buffer (pH 7.4), for 3 h at 4°C, followed by dehydration with a graded series of ethanol. Finally, the samples were dried in hexamethyl disilazane. Coating was performed using gold with a thickness of approximately 20 nm and samples were observed under under a scanning electron microscope (Leo 435 VP; LEO Electron Microscopy Ltd, Cambridge, UK).
Confocal microscopy on E. coli ATCC 11775
E. coli was grown to mid log phase in MHB (Difco), washed three times with buffer (10 mM NaCl/P i , pH 7.4) and resuspended in buffer to obtain 2 9 10 8 CFUÁmL À1 .
Different concentrations of FITC-labelled peptides, CS-1a and CS-2a (MIC and 4 9 MIC) were incubated with 1 mL of bacterial suspension for 30 min. After 30 min, the bacterial suspension was palleted down and washed three times with NaCl/P i . A drop of 20 lL of bacterial suspension was placed on a poly-lysine coated glass slide and air dried for 15 min. The samples were then subjected to confocal laser scanning microscopy (Axioplan 2 optical microscope; Zeiss, Tokyo, Japan) to visualize the internalization of fluorescent peptides into the live cells.
DNA-binding assay
Gel retardation experiments were performed for peptide CS-1a, CS-2a and indolicidin as described previously [48, 51] . Briefly 100 ng of plasmid DNA (pBluescript II SK+) was mixed with increasing amounts of peptide in 20 lL of binding buffer (5% glycerol, 10 mM Tris, pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, 20 mM KCl and 
Supporting information
The following supplementary material is available: Fig. S1 . ESI-MS spectra of FITC-CS-1a. Fig. S2 . ESI-MS spectra of FITC-CS-2a. Table S1 . Comparative antibacterial activity data of CS-1a, CS-2a and their FITC-tagged counter peptides. This supplementary material can be found in the online version of this article.
Please note: As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be reorganized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Introduction
The emergence of multiple drug resistant bacterial strains causes millions of deaths worldwide.
1,2 The rise in morbidity and mortality related to microbial infections has led to tremendous pressure on health care systems. 3 Host defense cationic peptides (HDCPs) are known for their wide range of activity against microorganisms including bacteria, fungi, viruses and even cancerous cells. With multifaceted roles in innate immunity and a direct cell lytic mode of action, it is difficult for a microorganism to endure resistance against HDCPs. 4, 5 Therefore HDCPs are being explored as promising alternatives to conventional drugs. 6, 7 However in spite of all these advantages only a handful of antimicrobial peptides are under clinical trials due to their high manufacturing costs, poor pharmacokinetic properties and associated toxicity issues. 8 To address these issues, efforts are being made to explore the characteristic features of HDCPs such as net positive charge at physiological pH and hydrophobic bulk 9 to develop more economic membrane active antimicrobial peptidomimetics. Many classes of compounds such as ceragenins, 10, 11 oligoacyllysines, 12, 13 arylamides, 14 peptoid based scaffolds 15 and lipopeptides 16, 17 that mimic HDCPs are being developed as alternative antimicrobial agents with low susceptibility for development of resistance.
Cationic polyamines spermine, spermidine and putrescine are ubiquitous components of eukaryotic and prokaryotic cells with multiple roles in modulating functions of DNA, RNA and proteins inside the cells. 18 A number of modified/conjugated polyamines have been reported with various biological activities such as LPS sequestration, 19 anti-parasitic activity, 20, 21 anticancer activity, 22, 23 as well as nucleic acid carriers for DNA transfection. 24 Considering the medicinal potential of polyamines we anticipated that incorporation of spermidine as a positively charged moiety to hydrophobic-dipeptides may lead to small peptidomimetics with better antibacterial activity.
Long-chain free fatty acids (FFAs) are known to be present at skin surfaces, maintaining an acidic pH which helps to prevent colonization of various microorganisms including methicillinresistant S. aureus and H. pylori. [25] [26] [27] The mode of bacterial killing for FFAs has not been unambiguously determined however, the prime target is believed to be microbial membranes where direct lysis, perturbation of the electron transport chain, oxidative phosphorylation and inhibition of fatty acid metabolism have been reported as some of the probable causes leading to bacterial cell death. 28, 29 Therefore with multiple nonspecific modes of action, a broad range of activity and minimum toxicity long chain FFAs were chosen to be incorporated into designed peptidomimetics as the hydrophobic moiety.
Here we report the design and synthesis of a small library of hydrophobic-dipeptide-spermidine template based sequences consisting of cationic polyamine spermidine and FFAs (linoleic acid and stearic acid). We dissected the template into two parts to evaluate the role of the hydrophobic moiety-dipeptide or cationic-dipeptide part of the template in imparting activity and/or selectivity to these sequences. We further evaluated interaction of the active sequences with model membranes, intact bacterial cells and DNA to probe into the molecular mode of action.
Results and discussion
Design and synthesis
Clinically approved lipopeptide antibiotics such as polymyxin B, daptomycin and echinocandins have spurred the research for novel analogues of these classes of lipopeptides with clinical relevance. [30] [31] [32] A large number of membrane active lipopeptides have been designed to achieve net positive charge (at least +2) and hydrophobic bulk making use of varied chemical moieties. [15] [16] [17] However, cationic lipopeptides with saturated fatty acids are difficult to optimize for cell selectivity. 33 Realizing the importance of charge and amphiphilicity for membrane active antimicrobial peptidomimetics, we designed a novel short template that comprised a hydrophobic moiety attached at the Nterminus to dipeptide-spermidine. The sequences presented in the current study are unique where inherently active unsaturated fatty acids were coupled to dipeptides which were further tagged with organic polyamine spermidine, prompting membrane activity as well as cellular translocation to bind DNA. For the dipeptide portion we made use of three different combinations of tryptophan (Trp) and ornithine (Orn) amino acids i.e. Trp-Trp, Trp-Orn and Orn-Orn. Hydrophobic Trp amino acid was chosen because of its well documented membrane anchoring property. 34 Cationic residue Orn was used to impart protease stability to designed sequences due to its non-ribosomal origin. Based on various biological activities associated with spermidine conjugates as outlined above, we incorporated spermidine at the C-terminus of the dipeptides to give rise to sequences 1-3 (Table 1) . N-Terminal hydrophobic tagging of dipeptide sequences was done to evaluate the role of FFAs such as linoleic acid and stearic acid in imparting activity leading to sequences 4-11. To evaluate the role of lipidation as a control an aromatic moiety 3-(4-hydroxyphenyl)-propionic acid (HPPA) was also conjugated. The HPPA was used based on our observations that covalent hybridization of HPPA to a tetra-peptide template led to the discovery of some potent tetra-peptidomimetics. 35 To have an appropriate balance between charge and hydrophobicity, the designed complete template consisting of a hydrophobic tag at the N-terminal with cationic spermidine at the C-terminus resulting in sequences 12-19 was also synthesized. With at least +2 charge and varied degrees of hydrophobicity these conjugates were further evaluated for antibacterial activity and mode of action studies.
The sequences were synthesized using a combination of solid phase and solution phase strategy as presented in Scheme 1. Structures of representative sequences are shown in Fig. 1 .
Antibacterial activity
Antibacterial activity of designed sequences against a range of Gram-positive and Gram-negative bacterial strains was determined using the serial broth dilution method ( Table 2) . Out of the sequences 1-3, sequence 1 exhibited MIC at 113.6 μg mL −1 against S. aureus. Out of sequences 4-11, 4, 5 and 9 were devoid of antibacterial activity, whereas sequences 6 and 7 showed MIC at 113.6 μg mL −1 against S. aureus and B. subtilis. Sequence 8 with +1 charge showed moderate activity against tested strains with MIC in the range of 28.4-113.6 μg mL −1 . Sequence 11 with +1 charge and stearic acid tagging showed . Percentage of acetonitrile from RP-HPLC elution profile data as an indicator for hydrophobicity along with MIC data showed that the designed sequences with a threshold of acetonitrile (50%) with a single positive charge (8 and 11) showed good antibacterial activity (Table 2) . Therefore similar to the previously reported concept of a hydrophobicity window for HDCPs, 36 here we propose a window of 50% to 70% acetonitrile at RP-HPLC elution (Table 1) , below or above this threshold the sequences were either less active or inactive. MIC data on these sequences thus ensured that lipidation with a single positive charge may lead to activity (8 and 11) however; charge alone (1-3) without lipidation is not sufficient to impart appreciable activity. respectively (except sequence 17). Against the four Gram-positive strains tested in the study, all the sequences showed MIC values below 15 μg mL −1 . Interestingly MIC of these sequences against MRSA was found to be comparable or even better as compared to S. aureus. Sequence 17 with 76% acetonitrile at RP-HPLC elution was above the hydrophobicity threshold of 70%, above which the sequences were found to be less active against tested strains. It is important to note that in comparison to standard antibiotics tetracycline and polymyxin B, sequences 14-19 showed better MIC against MRSA (except 17), where 14 and 15 were very promising with MIC at 0.88 μg mL −1 .
Toxicity evaluation of designed sequences
The efficacy of designed sequences as safe antibacterial agents was established based on their interaction with enucleated hRBCs and human keratinocytes (HaCaT cells). Most of the sequences (1-7, 9, 12, 13, 16 and 17) were found to be nonhemolytic up to 62.5 μg mL −1 . Sequences 8 and 11 were found to be lytic to hRBCs, however on conjugation of spermidine, reduction in hemolysis was observed for N-terminal tagged dipeptides (Table 2) . Sequences 14 and 16 showed negligible hemolytic activity whereas sequence 15 caused 40% hemolysis at concentrations corresponding to 18-78 times its MIC values against Gram-positive bacterial strains tested in the study. Sequences with stearic acid tagging (18 and 19) were found to be more lytic to hRBC than the linoleic acid counter sequences (15 and 16) . Similar to our results, experimental evidence is present in the literature that reports cationic lipopeptides with saturated fatty acid chain length to be more lytic as compared to their unsaturated counterparts. 33 Since HDCP mimics are considered more suitable as topical agents, we evaluated the effects of designed sequences on human keratinocytes. Results of the MTT assay on HaCaT cells showed 80% and 100% cell survival for sequences 14 and 16 at 62.5 μg mL −1 respectively (Fig. 2) . Even up to a high concentration of 250 μg mL −1 65% and 78% cell survival was observed for sequences 14 and 16 respectively. These data thus confirm no detrimental effects of these sequences on human keratinocytes even upon incubation for 18 h.
Bactericidal kinetics
HDCPs with a predominant membrane active mode of action are endowed with the potential to kill bacterial cells within minutes at concentrations higher than MIC. In order to monitor the rapidity of mode of action of designed sequences, we incubated sequences 14, 15 and 16 with log-phase MRSA at 37°C and monitored the course of change in optical density (OD 600 ) at different time intervals. The results showed inhibition of bacterial growth after 2 h at MIC for sequences 15 and 16 (Fig. 3) . was observed where at the highest concentration tested (7.87 μg mL −1 ) partial leakage of vesicle contents was observed (Fig. 4) . For 15 and 18 a rapid increase in fluorescent intensity due to a preferential pore forming ability was observed, where 18 caused a burst release of calcein dye at 1.99 μg mL −1 causing almost 72% leakage instantly. For sequences 17 and 19 moderate levels of leakage were observed where the maximum extent of leakage reached up to 60% and 51% respectively, at the highest concentration tested. These data make it clear that sequences with stearic acid conjugation lead to a better pore forming ability as compared to linoleic acid tagged sequences. Consistent with previous reports on HDCPs, the Trp-Trp dipeptide sequences 14 and 17 showed a preference to reside at the membrane interphase, causing relatively lower levels of calcein leakage. 34 Overall out of the active sequences, sequences 15 and 18 caused formation of large enough pores for complete leakage of encapsulated calcein dye whereas sequences 14 and 16 showed partial leakage and sequences 17 and 19 caused moderate levels of leakage. Standard antibiotic tetracycline showed less than 15% leakage up to the highest concentration tested.
Membrane depolarization
To study the mode of action on intact MRSA cells, a membrane depolarization experiment was performed. In this experiment if the sequences are able to alter membrane potential as a result of pore formation/membrane destabilization an increase in fluorescence intensity is observed. The data show concentration dependent effects and no perfect co-relation between MIC values and extent of membrane depolarization could be observed (Fig. 5) . The changes in fluorescence were instant with maximum increase within 2 min after treatment at all concentrations. Only a 48% increase in fluorescence intensity was caused by active sequences 14 and 17 even up to a concentration of 19.2 μg mL −1 . Sequences 15, 16, 18 and 19 lead to significant depolarization of membrane potential leading to an almost 78-96% increment in fluorescence at a concentration of 14.5 μg mL −1 . Concomitant with the depolarization experiment a PI uptake experiment was set up to evaluate if depolarization was a lethal event. The PI uptake data showed loss of viability upon treatment of MRSA with sequences at 19.2 μg mL −1 (data not shown here).
DNA binding
Antimicrobial potency of various classes of DNA binding agents is well reported in the literature. 37, 38 We accessed DNA binding ability of sequences 14-19 as the role of spermidine in membrane translocation as well as DNA complexation is well known.
39 Sequences 14 and 16 showed binding with DNA (100 ng) causing retardation at 12.5 μg mL −1 where for 16 slight retardation was observed even at 6.25 μg mL −1 (Fig. 6 ). Sequence 15 showed excellent DNA binding ability with complete retardation at 3.12 μg mL −1 . Sequences 18 and 19 showed good DNA retardation ability with complete binding at 6.25 μg mL −1 . Noticeably Trp-Trp sequences 14 and 17 showed poor DNA complexation which may in part be ascribed to lower charge density in these sequences. However it was intriguing that DNA binding was influenced by overall structure of the sequences as Trp-Orn dipeptide containing sequences 15 and 18 showed the most potent DNA retardation ability as compared to Orn-Orn analogues 16 and 19. Recently it was shown that a novel class of DNA minor groove binders based on benzophenone tetra-amide scaffolds showed strong DNA binding ability with membrane active bactericidal mode of action. 40 Therefore unexpectedly DNA binding was not directly involved with mode of action of this class of compounds. 41 On similar lines in the present study upon comparing DNA binding and antimicrobial potency (sequence 14 showed lesser DNA binding though was equipotent as 15) it was evident that there were no direct correlations between DNA retardation and antimicrobial potency/ mode of action.
Scanning electron microscopy
To have visual evidence for the membrane active mode of action, we incubated sequences 14, 15 and 16 with MRSA at concentrations higher than MIC. Disintegration of bacterial membranes due to pore formation or surface swelling have been microscopically observed for membrane active HDCPs at concentrations higher than MIC. 42, 43 Control MRSA cells exhibit a bright smooth appearance with an intact cell membrane (Fig. 7A) .
Membrane damage and cellular debris as small and round structures were apparent upon treatment of MRSA with sequence 14 (Fig. 7B) . In sequence 15 treated S. aureus cells, cellular protrusions as well as flattened cells due to complete leakage of cellular contents were visible (Fig. 7C) . For sequence 16 deformed outer membranes were observed where surface blabbing was visible without much leakage of cellular contents (Fig. 7D) . The appearance of such protrusions on the surface of S. aureus caused by HDCPs Gramicidin S and PGLa has recently been reported as well. 44 These data are in agreement with calcein leakage and membrane depolarization experiments where This journal is © The Royal Society of Chemistry 2012 sequence 15 caused cellular damage in the form of membrane disruption whereas 14 and 16 were found to show lesser leakage of encapsulated dye.
Overall the present study affords us sequences 14-19 with potent activity against a broad range of bacterial strains including MRSA. Upon dissecting the designed template to identify features responsible for activity and selectivity, we found that the cationic charge imparted to dipeptides by spermidine in sequences 1-3 was not sufficient per se to show bactericidal properties. Lipidation alone with neutral or negative charge in sequences 6, 7, 9 and 10 also led to low activity. With unit positive charge, lipidated sequences 8 and 11 exhibited improved activity though with compromised cell selectivity ( Table 2) . However conjugation of spermidine in sequences 14-19 improved potency as well as cell selectivity. With minimum +2 charges, lipidated sequences 14-19 showed a broad range of antibacterial activity.
Since the sequences show potent activity against MRSA, to have better insights into the mode of action of designed sequences we characterized their interactions with S. aureus mimic artificial membranes, intact MRSA and DNA.
Mode of action studies revealed a predominant role of the dipeptide sequence in initial binding, bactericidal kinetics and membrane disrupting abilities of designed sequences. For sequence 14, low leakage causing ability, lower levels of membrane depolarization as well as reduced DNA binding ability make membrane destabilization a less probable mode of action at MIC. A slower bactericidal kinetics of 14 at MIC might as well be due to different modes of action operative at low concentrations. Slower bactericidal kinetics has previously been reported for HDCP mimics interfering with vital functions in bacterial cells other than membrane disruption. 45 However in SEM studies at concentrations 10 × MIC cellular debris and diffused outer bacterial membranes were evident for 14 potentiating a membrane disruptive mode of action (Fig. 7B) . Sequence 15 showed faster leakage of calcein along with membrane depolarization, rapid killing kinetics and excellent DNA binding ability. Therefore this sequence showed clean membrane perturbing mode of action at MIC as well as higher concentrations as was evidenced in SEM images of the treated MRSA (Fig. 7C ). Sequence 16 with rapid bactericidal kinetics, good DNA binding ability caused appreciable damage to membrane potential in MRSA at the tested concentrations, however moderate levels of leakage causing ability showed that either transient pores were formed or the pores were not large enough to cause leakage of calcein which is evident by the surface blabbing observed in SEM studies. A low leakage causing ability in spite of potent membrane depolarization has previously been reported for analogues of HDCP indolicidin. 46 
Conclusion
In summary, using simple chemistry and economically viable building blocks FFAs (linoleic acid/stearic acid), Trp, Orn and spermidine, we obtained 6 active sequences with a broad range of activity against Gram-positive as well as Gram-negative bacterial strains including clinically relevant pathogen MRSA. Sequences 14 and 16 showed excellent cell selectivity and membrane perturbing mode of action at concentrations higher than MIC. These sequences were also able to alter the electrophoretic mobility of DNA which although was not directly related to activity may as well be responsible for further enhanced potency of these sequences due to intracellular mode of action. The structure-activity work in this study paves the way for the design of optimized FFAs based peptidomimetics with spermidine/spermine conjugated with different combinations of amino acids which is currently in progress in our laboratory.
Experimental section Materials
Fmoc-protected amino acids and resins were purchased from Novabiochem. Dimethylamino pyridine (DMAP), N,N-diisopropylcarbodiimide (DIPCDI), N-hydroxybenzotrizole (HOBt), diisopropyl ethylamine (DIPEA), N-methyl pyrrolidinone (NMP), piperidine, trifluoroethanol (TFE), trifluoroacetic acid (TFA), triisopropyl silane (TIS), calcein and 3,3′-dipropylthiadicarbocyanine iodide (DiSC 3 5) were obtained from Sigma Chemical Co. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) (POPG) were purchased from Avanti Polar Lipids. Dulbecco's modified Eagles' medium-high glucose (DMEM), antibiotic/antimycotic solutions, heat inactivated fetal bovine serum (FBS), trypsin from porcine pancreas and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) were obtained from Sigma Aldrich Chemical Company. All solvents used for the purification were of HPLC grade and obtained from Merck, Germany. Dimethylformamide (DMF) and dichloromethane (DCM) were obtained from Merck India. DMF was double distilled prior to use.
Synthesis and purification of sequences
The dipeptides were synthesized on 2-chlorotrityl chloride resin as a solid support using Fmoc chemistry as reported previously. 47 The terminal amino group of dipeptides was Boc protected on a solid support before cleavage from the resin under mild conditions (TFE : CH 3 COOH : CH 2 Cl 2 cocktail, 1 : 1 : 8) to retain Boc groups. The cleaved dipeptides were coupled with N 1 ,N 4 -bis(boc)spermidine (SIGMA) using HOBt and DIPCDI in dry tetrahydrofuran under a N 2 atmosphere at 0°C for 30 min followed by 18 h at rt as reported previously. 48 The obtained product was dissolved in CHCl 3 (15 mL) and washed with 1% aqueous NaHCO 3 (50 mL), 1% aqueous HCl (50 mL), and brine (50 mL). The organic layer was dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to give crude dipeptide spermidine conjugates. Boc groups were removed from the conjugates using 50% TFA in CH 2 Cl 2 to give sequences 1-3. On a solid support N-terminal end tagging of dipeptides was achieved by coupling 4 equiv. of 3-(4-hydroxyphenyl)-propionic acid (HPPA)/linoleic acid/stearic acid overnight with HOBt and DIPCDI. The Kaiser test was performed to check completion of reactions on a solid support. 49 The N-terminal tagged di-peptidomimetics were cleaved from a solid support under two different conditions. For synthesis of 4-11, cleavage was effectuated using 50% TFA in DCM. For synthesis of 12-19, cleavage was performed under mild conditions (TFE : CH 3 COOH : CH 2 Cl 2 cocktail 1 : 1 : 8). Further Boc protected N-terminal tagged conjugates were coupled with N 1 ,N 4 -bis(boc) spermidine as described for dipeptides earlier in the text. Finally Boc groups were removed with 50% TFA resulting in sequences 12-19. Synthesized sequences were purified using an RP-HPLC column (7.8 × 300 mm, 125 Å, 10 μm particle size) with either gradients of 10 to 90% buffer 2 where buffer 1 was water (0.05% TFA) and buffer 2 was acetonitrile (0.05% TFA) over 45 min or 30 to 100% buffer 2 gradients were run over 45 min where buffer 1 was water (0.1% TFA) and buffer 2 was acetonitrile (0.1% TFA). The correct sequences after purification were confirmed by LC-MS/MS (Quattro micro API, Waters), LC-ESI-HRMS on UHPLC (Dionex, Germany) and LTQ Orbitrap XL (Thermo Fisher Scientific, USA) mass determination and 1 H NMR. Mass spectra, analytical HPLC traces and 1 H NMR data of representative sequences are provided in supplementary files.
Antibacterial activity
Antibacterial activity of designed sequences was evaluated using a modification of the serial broth dilution method as reported previously. 50 Bacterial strains used in this study were as follows, 5 CFU mL −1 ) without test sequences were used as a positive control. Un-inoculated MHB was used as a negative control. Tests were carried out in duplicate on three different days. Minimum inhibitory concentration (MIC) is defined as the lowest concentration of test sequences that completely inhibits growth. For comparison peptide antibiotic polymyxin B and tetracycline were also assayed under identical conditions.
Hemolytic activity
Hemolytic activity assay was done as described previously. 51 Briefly, 100 μL of fresh hRBC suspension 4% v/v in PBS (35 mM phosphate buffer, 150 mM NaCl) was placed in a 96-well plate. After incubation of the test sequences (100 μL) in the erythrocyte solution for 1 h at 37°C, the plates were centrifuged and the supernatant (100 μL) was transferred to fresh 96-well plates. Absorbance was read at 540 nm using an ELISA plate reader (Molecular Devices). Percent hemolysis was calculated using the following formula:
where A represents absorbance of sample wells at 540 nm and A 0 and A t represent zero percent and 100% hemolysis determined in PBS and 1% Triton X-100, respectively.
Cytotoxicity
To assess cell viability, the MTT assay was performed as described previously. 52 HaCaT keratinocytes, 3000 cells per well, were seeded in 96-well plates in DMEM HAMS F12 media supplemented with 10% serum (FBS) to grow overnight. The next day media were aspirated and fresh incomplete media were added (50 μL per well). To the wells serial two-fold dilutions of different test sequences (50 μL) were added and the plates were incubated at 37°C with 5% CO 2 for 18 h. After 18 h the media were aspirated and 100 μL of MTT solution was added to each well. The plates were further incubated for 4 h in CO 2 at 37°C. After 4 h the MTT-containing medium was removed by aspiration. The blue formazan product generated was dissolved by the addition of 100 μL of 100% DMSO per well. The plates were then gently swirled for 2-3 min at room temperature to dissolve the precipitate. The absorbance was monitored at 540 nm. Percentage viability was calculated based on the following formula:
where A represents sample absorbance at a given concentration and A control represents untreated cells. The experiment was repeated thrice and results are given as mean ± SD.
Bactericidal kinetics
Overnight cultures of methicillin resistant S. aureus (ATCC 33591) were grown in fresh MHB up to log phase. For determining the time course of killing activity 100 μL of fresh MHB was added to all wells of the 96 well-plate. Then 90 μL of approximately 10 5 CFU mL −1 were added to the wells of the 96-well plate (4 wells for a single concentration). Then 10 μL of appropriate concentrations of test sequences corresponding to MIC and 4 × MIC were added to the wells. The plates were incubated at 37°C at 200 rpm. Absorbance of the plates was read at 600 nm at various time points at 0, 1, 2, 3, 4 and 5 h. The experiment was repeated on three different days and values are plotted as mean ± SD.
Calcein leakage
The ability of designed sequences 14-19 to cause leakage from artificial LUVs composed of bacterial mimic membrane (POPC/ POPG) was accessed as described previously. 53, 54 Briefly, desired mixtures of the lipids POPC/POPG (7 : 3, w/w) were dissolved in a 2 mL chloroform-methanol mixture in a 150 mL round bottom flask. The solvent was removed under a stream of nitrogen and the lipid film obtained was lyophilized overnight to remove any traces of organic solvent. The dry lipid films were rehydrated with 10 mM Tris-HCl [70 mM calcein, 150 mM NaCl, 0.1 mM EDTA]. The liposome suspension obtained after rehydration was freeze thawed for five cycles and extruded 16 times through two stacked polycarbonate filters (Mini extruder, Avanti Polar Lipids). Free calcein was removed by passing the liposome suspension through a Sephadex G-50 column at 23°C and eluting with a buffer containing 10 mM Tris-HCl [150 mM NaCl, 0.1 mM EDTA]. After passing the liposome through a Sephadex G-50, liposome diameter was measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments). The average diameter of LUVs was found to be in the range of 90-110 nm. Different concentrations of test sequences were incubated with POPC/POPG LUVs for 5 min before exciting the samples. Leakage was monitored by measuring the fluorescence intensity at an emission wavelength of 520 nm upon excitation at 490 nm on a model Fluorolog (Jobin Yuvon, Horiba) spectrofluorimeter. A slit width of 3 nm was used for both excitation and emission. Percentage dye leakage was calculated using the formula
where F is the fluorescence intensity achieved by addition of different concentrations of sequences. F 0 and F t are fluorescence intensities in buffer and with Triton X-100 (20 μL of 10% solution) respectively. All measurements were made in duplicate and less than 4% deviation was obtained in the data points. A phosphate assay was performed to determine the concentration of lipids for the leakage experiment. 55 
Membrane depolarization
For the evaluation of membrane depolarization a previously defined method was used. 56 Briefly, overnight grown MRSA was subcultured into MHB for 2-3 h at 37°C to obtain midlog phase cultures. The cells were centrifuged at 4000 rpm for 10 min at 25°C, washed, and re-suspended in respiration buffer (5 mM HEPES, 20 mM glucose, pH 7.4) to obtain a diluted suspension of OD 600 ≈ 0.05. A membrane potential-sensitive dye, 3,3′-dipropylthiadicarbocyanine iodide (DiSC 3 5), 0.18 μM ( prepared in DMSO) was added to a 500 μL aliquot of the re-suspended cells and allowed to stabilize for 1 h. Baseline fluorescence was acquired using a Fluorolog (Jobin Yuvon, Horiba) spectrofluorometer by excitation at 622 nm and emission at 670 nm. A bandwidth of 5 nm was employed for excitation and emission. Subsequently, increasing concentrations of test sequences between 2 and 19.2 μg mL −1 were added to the stabilized cells and the increase of fluorescence on account of the dequenching of DiSC 3 5 dye was measured after every 2 min to obtain the maximal depolarization. Percent depolarization was calculated by using the formula
where F is the fluorescence intensity 2 min after addition of sequences, F 0 is the initial basal fluorescence intensity, and F m is the maximum fluorescence intensity obtained after addition of 10 μg mL −1 gramicidin. Percent depolarization mean ± SD of two independent experiments was plotted versus increasing concentrations of different sequences.
DNA binding assay
Gel retardation experiments were performed as described previously. 54, 57 Briefly, 100 ng of plasmid DNA ( pBluescript II SK+) was mixed with increasing amounts of test sequences 14-19 in 20 μL of binding buffer (5% glycerol, 10 mM TrisHCl, pH 8.0, 1 mM EDTA, 1 mM dithiothreitol, 20 mM KCl, and 50 μg mL −1 bovine serum albumin). Reaction mixtures were incubated at room temperature for 1 h. Subsequently, 4 μL of native loading buffer was added (10% Ficoll 400, 10 mM TrisHCl, pH 7.5, 50 mM EDTA, 0.25% bromophenol blue, and 0.25% xylene cyanol), and a 20 μL aliquot subjected to 1% agarose gel electrophoresis in 0.5× Tris borate-EDTA buffer (45 mM Tris-borate and 1 mM EDTA, pH 8.0). The gels were run for 1.5 h at 80 V and visualized with ethidium bromide. The plasmid DNA was purchased from Stratagene and was used as such without further purification.
Scanning electron microscopy
For electron microscopy samples were prepared as described previously. 58 Briefly, freshly inoculated methicillin resistant S. aureus (ATCC 33591) was grown on MHB up to an OD 600 of 0.5 (corresponding to 10 8 CFU mL −1 ). Bacterial cells were then spun down at 4000 rpm for 15 min, washed thrice in PBS (20 mM, 150 mM NaCl) and re-suspended in an equal volume of PBS. The cultures were then incubated with test sequences 14, 15 or 16 at 10 × MIC for 30 min. Controls were run in the absence of sequences. After 30 min, the cells were spun down and washed with PBS thrice. For cell fixation the washed bacterial pallet was re-suspended in 1 mL of 2.5% glutaraldehyde in PBS and was incubated at 4°C for 4 h. After fixation, cells were spun down and washed with PBS twice. Further the samples were dehydrated in series of graded ethanol solutions (30% to 100%), and finally dried in desiccators under a vacuum. An automatic sputter coater (Polaron OM-SC7640) was used for coating the specimens with 20 nm gold particles. Then samples were viewed via a scanning electron microscope (EVO 40, Carl Zeiss, Germany).
